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Abstract 
 
Osteoporosis is one of the most common public health problem affecting adults and 
elderlies, it called silent disease because most individuals are not aware they have 
osteoporosis until they actually fracture a bone. This study aim to identify the possible risk 
factors for osteoporosis among adults in Gaza Governorate. The researcher used a case-
control study to identify risk factors of osteoporosis. Cases and controls were selected from 
Palestinian German Diagnostic Center after doing DEXA scan a standard method for 
diagnosis of osteoporosis depend on giving T score (Tscore< -2.5 osteoporosis, T score >-
1 normal). Structure interview questionnaire was used and information on socio-
demographic characteristics, life style, medical conditions  and medication used were 
collected. Data was processed and analyzed using statistical package for social sciences 
(SPSS) version 20. Binary logistic regression was used to control confounders. A total of 
160 participants were participated in the study 80 cases and 80 controls.The logistic 
regression analysis adjusted for age, sex and place of treatment showed that there was 
significant risk factors between development of osteoporosis and breast-feeding [(OR: 
1.436, 95%C.I.: 1.436-26.842), P value = 0.015], while BMI >29.9 showed a protective 
factor for osteoporosis [(OR: 0.871, 95%C.I.: 0.796-0.954), P value= 0.003]. In addition, 
significant risk factor was shown between family history and development of osteoporosis 
[(OR: 3.845, 95%C.I: 1.283-11.520), P value= 0.016]. Furthermore, there was a 
significant risk factor between using loop diuretics (Lasix) and development of 
osteoporosis [(OR: 6.967, 95%C.I.: 1.362-35.649), P value = 0.020]. Finally, significant 
risk factor between using antihypertensive drug and development osteoporosis [(OR: 
3.004, 95%C.I.: 0.978-9.228), P value= 0.05]. Therefore, the findings from our study 
suggest the need to pay attention for mother using breast-feeding to improve their nutrition 
during this period. In addition, special effort need to focus on causes of secondary 
osteoporosis as using loop diuretics, anti-hypertensive drugs and family history of 
osteoporosis. Strategies about health education program at primary and secondary level 
should be started to reduce the incidence of osteoporosis. 
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 ممخص الدراسة
دراسة الحالات : عوامل الاختطار لمرض ىشاشة العظام بين البالغين في محافظات غزة: "ىذه الدراسة بعنوان
عمى الصعيد العالمي يعتبر مرض ىشاشة العظام من مشاكل العظام الأكثر شيوعًا حول العالم ". والشواىد
والتي تؤثر خاصة عمى البالغين وكبار السن ويدعى ىذا المرض بالمرض الصامت حيث لا يعمم المصاب بو 
 .حتى يصاب بكسر بأحد عظامو
، حيث ) حالة سميمة08 حالة مصابة بمرض ىشاشة العظام و 08(حالة  )061(تكونت عينة الدراسة من 
استخدم الباحث دراسة مقارنة بين الحالات المرضية والحالات السميمة ، وقد ُأخذت جميع الحالات من المركز 
المختص  )AXED(الفمسطيني الألماني التشخيصي خلال فترة جمع العينة؛ وذلك بعد إجراء فحص الدكسا 
 .بكشف مرض ىشاشة العظام لكل من الحالات والشواىد
 العوامل الاجتماعية(تكونت أداة الدراسة من استبانة تم إعدادىا لقياس متغيرات الدراسة 
 ، وقد قام الباحث بإجراء ) الديموغرافية، نمط العيش، الوضع الصحي الطبي، الأدوية المستخدمة
  حالة 02اختبارات الصدق والثبات للاستبانة من خلال عينة استطلاعية تكونت من 
، وقد تم تضمينيم في عينة  الدراسة، وقد استخدم الباحث الحزمة ) شواىد01 حالات و 01(
لإجراء بعض الاختبارات الإحصائية  ))SSPS( ecneicS laicoS fo egakcaP lacitsitatS(الإحصائية
 .مثل مربع كاي والانحدار المتعدد
وقد أظير اختبار الانحدار المتعدد لإيجاد عوامل الاختطار لمرض ىشاشة العظام أن ىناك علاقة ذات دلالة 
الرضاعة الطبيعية، التاريخ العائمي للإصابة بالمرض، (إحصائية بين الإصابة بمرض ىشاشة العظام وبين 
في حين أن زيادة الوزن اعتبرت كعامل حماية من  )استخدام مدرات البول اللازكس، استخدام أدوية الضغط
 .الإصابة بمرض ىشاشة العظام
كذلك أظيرت نتائج الدراسة أن الحالات التي تستخدم الرضاعة الطبيعية تزداد معدل إصابتيم بالمرض بمعدل 
أكثر من النساء المواتي يستخدمن الرضاعة الصناعية لأطفالين كما وأظير الانحدار المتعدد  )634.1 :RO(
أن الحالات التي لدييا تاريخ عائمي للإصابة بمرض ىشاشة العظام تزداد معدل إصابتيم بالمرض بمعدل 
أكثر من الذين ليس لذوييم تاريخ عائميملإصابة بمرض ىشاشة العظام، كما وأظيرت النتائج  )548.3:RO(
أن الحالات التي تتناول أدوية مثل مدرات البول اللازكس وأدوية الضغط تزداد معدل الإصابة لدييم بمرض 
عمى التوالي أكثر من الذين لا يستخدمون مثل ىذه  )400.3 :RO ;769.6 :RO(ىشاشة العظام بمعدل
 .الأدوية
 :RO(في حيث أظيرت نتائج الدراسة أن زيادة الوزن تشكل عامل حماية من الإصابة بمرض ىشاشة العظام 
 .من الأشخاص الذين يعانون من النحافة )178.0
وتوصي ىذه الدراسة بالاىتمام بعوامل الاختطار الناتجة عن استخدام بعض الأدوية المسببة لمرض ىشاشة 
 .العظام
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1 Chapter 1: 
Introduction 
1.1 Research background 
The patient profile in health institutions all over the developing world is changing. Non-
communicable diseases (NCDs) have already established themselves as the predominant 
cause of disease and death inmanymiddle-income countries (WHO, 2010). Bone health is 
critically important to the overall health and quality of life. Healthy bone provide body 
with a frame allow for mobility and for the protection against injury (U.S. Department of 
Health and Human Service, 2004). 
Osteoporosis, or porous bone, define by the International Osteoporosis Foundation (IOF) 
as  a disease in which the density and quality of bone are reduced, leading to weakness of 
the skeleton and increased risk of fracture, particularly of the spine, wrist, hip, pelvis and 
upper arm (International Osteoporosis Foundation-IOF, 2011). 
Osteoporosis is one of the common bone disease occurs most commonly in 
postmenopausal women whilemale osteoporosis has also gained attention as a growing 
public health concern (Mauck and Clarke, 2006). 
Fracture is the most dangerous aspect of osteoporosis. In the elderly, it may lead to 
disability, morbidity and early mortality. In Osteoporosis, bone become fragile and may 
break from minor falls or in serious cases even from simple action as sneezing or bumping 
into furniture this condition can cause pain, difficulty of breathing and loss of 
independency and even death (Berry et al., 2010).There were an estimated nine million 
osteoporotic fractures worldwide in 2000, of which 1.6 million were hip, 1.7 million 
forearm, and 1.4 million clinical vertebral fractures (Boonen and Singer, 2008). 
According to A Report of the Surgeon General (2004), Bone strength related to bone mass 
density, which refers to the amount of mineralization remaining in bones as people age and 
the denser the bones, the stronger they are. Factors that determine bone strength include 
genetic, environment, medication, Ethnicity (African-Americans have higher bone density 
than Caucasians or Asians), Gender (men have higher bone density than women), Aging 
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(bone density reaches its peak around age 25, and decreases after age 35)(U.S. Department 
of Health and Human Service, 2004). 
Osteoporosis also called the "silent disease" because most individuals are not aware they have 
osteoporosis until they actually fracture a bone (usually the hip, spine, or wrist) (National 
Osteoporosis Foundation-NOF, 2002). 
Clinically, bone mass density (BMD) is the main determinant of osteoporosis it can mainly 
diagnose by dual-energy X-ray absorptiometry (DEXA) scan (Watts et al., 2008). The 
World Health Organization (WHO) has established criteria for making the diagnosis of 
osteoporosis, as well as determining levels that predict higher chances of fractures. These 
criteria is based on comparing the BMD of the patient with that of a typical healthy young 
female's (WHO, 1994).  
According to researcher knowledge there is limited study indicates the prevalence and 
burden of osteoporosis among people live in Gaza Governorates (GG). Therefore, the 
researcher conducted this study to determine different risk factors associated with 
osteoporosis among people live in Gaza Governorate (GG) that might be enable policy 
maker to make decision to decrease the burden and incidence of osteoporosis. 
1.2 Research Problem 
As outlined in the Report of the Surgeon General, Osteoporosis is the most common bone 
disease in humans, and it represents a major public health problem (U.S. Department of 
Health and Human Service, 2004). Moreover, National osteoporosis Foundation (NOF) 
consider Osteoporosis behaves as a silent killer therefore, a high percentage of the affected 
people are not aware they have this chronic condition (NOF, 2002). Despite its importance, 
the etiology of osteoporosis and the key to its prevention remain poorly understood and 
studied among people live in Gaza Governorate (GG). 
Osteoporosis is globally important health problem with serious consequence in both 
developed and developing country. In Middle East, the International Osteoporosis 
Foundation (IOF) considers osteoporosis as a neglected health problem that basic 
epidemiological studies are lacking; additionally there is an absence of any statistical 
evidence regarding incidence of major osteoporotic fractures and a lack of government 
involvement in the prevention of osteoporosis(El-Hajj Fuleihan et al., 2011).Furthermore, 
vitamin D deficiency is highly prevalent in Middle Eastern countries and might be a strong 
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contributing factor for osteoporosis in spite of the availability of sun most the time around 
year (Gannagé‐Yared et al., 2000).  
The Palestinian Osteoporosis Prevention Society (POPS) conducted a study on the 
prevalence of osteoporosis among postmenopausal women published in May 2010   and it 
was found that around 40% of postmenopausal women were affected (Abd-Alhameed et 
al., 2010). 
Gaza Strip (GS) is consider one of these developing country and osteoporosis is a 
neglected health problem and do not has apriority by Ministry of health (MOH) or United 
Nations Relief and Work Agency (UNRWA) the main health providers in GS unlike other 
non-communicable disease that affected high percentage of the population such as diabetes 
and hypertension. In this study, the researcherhighlight about the different risk factors 
associated with osteoporosis among people live in GG as people suffer from many crisis 
results from siege and wars done by the Israel military occupation. 
1.3 Justification of the Study 
Osteoporosis affects an enormous number of people, of both sexes and all races, and its 
prevalence will increase as the population ages increase.Approximately 1.6 million hip 
fractures occur worldwide each year and this number could triple or quadruple and reach 
between 4.5 and 6.3 million by the year 2050 that make osteoporosis a global disease 
(Roux et al., 2012).  
Although risk factors for osteoporosis have been commonly studied worldwide, neither 
well-formed study nor systematic survey have been conducted to evaluate either the risk 
factors of osteoporosis or the short and long term consequence of fractures result from 
osteoporosis. Greater efforts are need to improve the awareness of risk factors of 
osteoporosis among people live in the Gaza Governorate. 
As there is a limited study, assess the risk factors of osteoporosis among people in Gaza 
Governorate according to the researcher knowledge, so the burden of osteoporosis will 
increase dramatically with advancing of age of the population.  
The life expectancy is expected to increase during the coming years to reach 74 years for 
males and 75 years for females (PCBS, 2016). The increase of life expectancy rate resulted 
in the increase of the elderly number in Palestine, which requires studying and researching 
the elderly situation in Palestine.  
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However, if we identify the main risk factors associated with osteoporosis we can made 
primary prevention of the disease by increase awareness of risk factors for osteoporosis 
among the population to improve health of the bone. Nevertheless, if factors still neglected 
the incidence and prevalence of osteoporosis will increase among population. 
1.4 Study Objectives 
1.4.1 General Objective 
The overall objective of this study is to determine the main risk factorsof osteoporosis 
among adultsin Gaza Governorates. 
1.4.2 Specific Objective 
1- To identify the main risk factors of osteoporosis among case and control group. 
2- To investigate an association between socio-demographic factors and osteoporosis 
in Gaza governorates. 
3- To determine an association between different life style habits and osteoporosis 
among case and control group. 
4- To explore medical condition that contributes to occurrence of osteoporosis. 
5- To assess the association between use of certain types of drugs and occurrence of 
osteoporosis. 
6- To suggest recommendation for stakeholder and policy makers in Ministry of 
Health (MOH) and different health care provider that positively influence reducing 
of occurrence of osteoporosis among people live in Gaza governorate. 
1.5 Research Question 
The study will tend to answer these questions:- 
1- What are the possible risk factorsof osteoporosis in Gaza governorate? 
2- Are there significant associations between the socio-demographic factors such as 
(occupation, education level, and family income) and occurrence of osteoporosis? 
3- Do maternal related factors such as (number of children, abortion and breast-
feeding) contributes to osteoporosis? 
4- Are there significant associations between life style habits such as (body mass 
index BMI, smoking,milk and dairy products intake, exercise activity, sun 
exposure, and using aluminum cookware) and occurrence of osteoporosis? 
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5- Is there a relation between drinking tea, coffee and soft drinks (cola) and 
occurrence of osteoporosis? 
6- Is there a significant association between family history and developing of 
osteoporosis? 
7- What are the main medical condition associated with developing of osteoporosis? 
8- Isthere an association between menstrual history and emerging of osteoporosis? 
9- Are there a significant association between using certain type of drug such as 
(corticosteroid, antihypertensive, anti-diabetic drug, anticoagulant(heparin), proton 
pump inhibitors drugs and loop diuretics) and developing of osteoporosis? 
1.6 Context of the Study 
1.6.1 Demographic Context 
The entire area of Palestine is 27,000square kilometer. It has an important strategic 
location as it is situated on the western edge of the continent of Asia, the eastern coastal 
extremely of the Mediterranean Sea. Palestine is bordered by Lebanon in north Syria and 
Jordan in the east, the Gulf of Aqaba in the south and by Egypt and Mediterranean Sea 
west(MOH,2015). 
Gaza Strip (GS) is a narrow land, located on the south of Palestine on the coast of 
Mediterranean sea. GS characterize by high population density with more than 4,500 
individuals per square kilometer that create high demand on health services. GS is 
classified into five governorates, North of Gaza, Gaza city, Mid-Zone, Khan-younis and 
Rafah. The life expectancy of Palestinian female is 73.34 years and male 70.67 years.By 
mid-2015, the total population of Palestinian country was 4 682 467, with 61.1% living in 
the west bank, including east Jerusalem, and 38.9% in Gaza strip. Two million are 
registered refugees of whose 800 000 live in 27 refugee camp, 19 in the west bank and 8 in 
the Gaza strip. The population is young with 39.4%of Palestinian aged 0-14 years , 30% 
aged15-29 years, and 4.5%above 60 years (PCBS, 2016). 
Elderly People in Palestine represent 4.5% of the total population in mid-2015 The 
Palestinian society is considered a young society where the percentage of children is high 
and the percentage of the elderly is relatively little.  In mid of the year 2015, the percentage 
of the elderly aged 60 and over reached 4.5% of the population in Palestine (4.9% in West 
Bank and 3.8% in Gaza strip). Life expectancy has  increased about 5-8 years during the 
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last two decades for both males and females. The life expectancy is expected to increase 
during the coming years to reach 72.8 years for males and 75.7 years for females in the 
year 2020.  The increase of life expectancy rate at birth resulted in the increase of the 
elderly number in Palestine, which requires studying and researching the elderly situation 
in Palestine (PCBS, 2016). 
1.6.2 SocioeconomicsSituation 
The Palestinian economy has been in decline since 2012 and estimates at the end of 2014 indicated 
a contraction in gross domestic product of 2.5% compared with 2013. (PCBS, 2015). Restrictions 
on movement and access, including the blockade of the Gaza Strip, the barrier wall on the West 
Bank and the permit regime, have contributed to the worsening economic conditions. 
Private sector development has also been hindered by the fragmented legal and regulatory 
business environment, which varies in the Gaza Strip, east Jerusalem and the different 
areas of the West Bank, and by the restrictions imposed on the movement of people and 
goods, and on trade between the West Bank, east Jerusalem and the Gaza Strip ( World 
Bank, 2014). 
The unemployment rate had declined to 16.0% in the West Bank, but had increased to 
45.1% in the Gaza Strip. One quarter of the Palestinian population lives in poverty, with 
the poverty rate in the Gaza Strip twice as high as in the West Bank. (World Bank, 2014). 
1.6.3 Health Profile 
The population of the occupied Palestinian territory is in an epidemiological transition, 
with the burden of non-communicable disease rising. In 2014, heart disease was the 
leading cause of death causing(31.2%) of all reported death. Cancers when combine 
together, where the second leading cause of death accounting for (14.2%), followed by 
cerebrovascular disease (11.3%), diabetes mellitus(8.9%) and prenatal condition(5.2%). 
This diseases increase the cost in the health sector and necessitatea greater focus for health 
prevention (MOH, 2015). 
1.6.4 Health Care Services Context 
Palestinian health care system is a complex system; it has four main provider for health 
care services: Ministry of Health (MOH), United Nations Relief and Works Agency 
(UNRWA), Non-governmental organization (NGOs) and private for profit service 
provider.  
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MOH is consider the main health provider. However, the Ministry of Health (MOH), 
UNRWA and nongovernmental organizations (NGOs) together provided geographical 
coverage of primary and hospital level services. The financial crisis affecting the 
Palestinian Authority continued to have a serious impact on the scope and quality of 
Ministry of Health services. Budget shortfalls have resulted in chronic shortages of 
essential drugs and medical disposables in the Gaza Strip. The restrictions imposed on the 
movement of health staff and goods hinder the overall functioning and development of the 
health system (World Bank, 2014). 
 
In 2014, the number of Palestinian fatalities and injuries resulting from war associated with 
military occupation was the highest since 1967, amounting to 2333 deaths and 15 788 
injuries – primarily occurring during the conflict in the Gaza Strip in July‒August 2014. 
The conflict had a significant impact on the daily life of Palestinians, with half a million 
people being displaced, of whom 100 000 remained homeless at the end of 2014, and some 
22 000 homes being either totally destroyed or rendered uninhabitable (OCHA, 2014). In 
addition, infant and under-five mortality rates continued to decline. In 2013, infant 
mortality was 12.9 deaths per 1000 live births, compared with 20.8 deaths per 1000 live 
births in 2005. The under-five mortality rate was 15.5 deaths per 1000 in 2013, down from 
24.6 deaths per 1000 in 2005 (MOH, 2016). 
 
The health status of Palestine refugees has shown sizable improvement. Deaths of mothers 
and children have been considerably decline. Non-communicable diseases or so-called 
Life-style illnesses are becoming predominant. According to UNRWA report, (2016) 
Evidence indicates that non-communicable diseases account for 70% to 80% of deaths 
among Palestine refugees. These are life-long, difficult to prevent and hard to control 
health conditions. Prevailing social and economic difficulties and political instability also 
negatively affect health outcomes (UNRWA, 2016). 
1.6.5 Palestinian GermanDiagnostic Center 
The center was established at 2007. The Palestinian German Diagnostic Center 
providediagnostic medical services such as MRI, DEXA Scan and X-Ray. The center 
vision is to raise the level of diagnosis and provide the sophisticatedequipment's that are 
necessary for early detection of various disease. It is the only center having DEXA scan in 
Gaza city and the second center among Gaza strip followed Al-Wafa hospital.  
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1.7 Operational Definition 
Osteoporosis case: The researcher define cases group as people whom diagnosed 
established by physician confirmed by doing DEXA scan. Cases were taken from the 
Palestinian German Diagnostic Center the only center in Gaza city had DEXA scan 
instrument. 
Osteoporosis control: The researcher define controls as people whom diagnosis confirmed 
by physician that they are free from osteoporosis after doing DEXA scan. Controls were 
matched with cases from age, gender and the place of treatment. 
Risk factors: Define by the researcher as those factors that may lead to osteoporosis 
include socio-demographic, life style, medical and medication use factors. 
Socio-demographic factors: The researcher define socio-demographic factors 
operationally as family and social status related condition that have an impact on increased 
risk of osteoporosis. 
Life style factors:The researcher define life style factors operationally as bad habits that 
increase risk of osteoporosis such as drinking coffee, tea and soft drink (cola), sedentary 
life style and calcium/ vitamin D deficiency. 
Medical condition factors: The researcher define medical factors operationally as medical 
related conditions that have shown impact on increased risk of osteoporosis such as family 
history of osteoporosis, rheumatoid arthritis, personal fracture and eating disorder. 
Medication factors: the researcher define medication factors operationally as medication 
used that related to increase risk of osteoporosis.Drugs as anticonvulsant, Lasix, 
contraceptive, corticosteroid and anti-hypertensive drug. 
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1.8 Lay Out of the Study 
This study consist as a generalform five chapters: introduction, conceptual framework and 
literature review, methodology, results and discussion,finally conclusion and 
recommendation. 
The first chapter presents ageneral introduction of the study, in which a brief background 
about the study interest  were given, the research problem, justification for study, the 
general and specific objectives, the context of the study and definition of terms. 
The second chapterincludes two parts: the first is conceptual framework where the 
researcher represents a diagram of the main study variables. The second parts the literature 
reviewof previous studies related to the study topic and variables. 
The third chapter revealed the methodology including study design, study setting, study 
population, sample size and sampling process, period of the study,eligibility criteria, data 
collection instrument, validity and reliability, pilot study, data collection, data management 
and statistical analysis, ethical and administrative considerations and finally the study 
limitation. 
The fourth chapter represent the results and discussion where the researcher display the 
study result in form of tables and figures with clarifying comments. Then these results 
were discussed in relation with previous study mentioned in the literature. 
The fifth chapter the researcher write her conclusion and recommendation according to the 
results of the study. 
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2 Chapter2 
Conceptual Framework and Literature Review 
In this chapter, the researcher represents the conceptual framework and literature review of 
the study themes and variables. In depth information regarding the main concepts and 
variables, beside previous studies were mentioned. 
2.1 Conceptual Framework 
Conceptual framework represents a way of thinking about a problem or a study, or away of 
representing how complex thing work. Researcher constantly uses conceptual framework 
to guide his work. Conceptual framework illuminate individuals work and illustrates 
several variables and outcomes, and their interrelation (Bordage, 2009). 
In this chapter, the researcher reviews the critical points of the study variables that are 
related to developing osteoporosis. As well as, the researcher reviews relevant previous 
studies and experience of other researcher in this field. After that, the researcher was able 
to sketch map-showing line of the interdependence of the factors, which contribute in the 
development of osteoporosis. 
There are several factors related and affecting the occurrence of osteoporosis. Time 
restriction and the nature of the study did not allow studying all the factors and therefore 
the researcher focused on part of these variables and developed new brief model (Figure 
2.1). 
The first domain consist of socio-demographic  risk factors which may influence the 
occurrence of osteoporosis among people live in Gaza strip which include education, 
family income, marital status and occupation.While, the second domain consist of life style 
risk factors which were suggested to developed osteoporosis and these factors are Body 
Mass Index (BMI), nutrition style (tea, coffee, soft drinks, milk and dairy product), 
calcium and vitamin D supplement, physical inactivity, smoking, sun exposure and using 
Aluminum cookware. 
The third domain consisted of medical condition that affecting bone and cause osteoporosis 
and it includes cancer, chronic constipation, chronic diarrhea, depression, diabetes 
mellitus, hypertension, eating disorder, family history, personal fracture, hyperthyroidism 
and hyperparathyroidism. The fourth and final domain consist of medication used that 
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developed osteoporosis and it include of anticoagulant(heparin), 
Glucocorticoid(Prednisolone), Anticonvulsant, loop diuretics (Lasix), proton pump 
inhibitorsPPIs, breast and prostate cancer drugs, contraceptive. 
The following conceptual framework consists of four domains as shown, each dimension 
represent multivariable to measure the associated factors. 
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Conceptual Framework 
 
 
   
 
 
   
 
  
  
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure (‎2.1):Conceptual framework (self-developed model) 
 
This model consists of dependent variable (osteoporosis) and independent variable (risk 
factors). 
 
 
 
Risk factors of Osteoporosis 
 
- Education 
- Family 
Income 
- Marital 
Status 
- Occupation 
- Body Mass 
Index (BMI) 
-  Nutrition Style ( 
Tea , Coffee, 
Soft Drinks, 
Milk, Dairy 
Product, 
Calcium And 
Vitamin D)   
- Physical Activity 
- Smoking 
- Sun Exposure 
- Using 
Aluminum 
Cookware 
- Cancer  
- Chronic asthma 
- Chronic constipation 
- Chronic diarrhea 
- depression 
- Diabetes mellitus DM 
- Hypertension 
- Eating disorder 
- Family history  
- Personal Fracture 
history 
- Hyperthyroidism and 
hyperparathyroidism 
- Stroke 
- Anticoagulant 
(heparin) 
- Glucocorticoid 
(Prednislone) 
- Anticonvulsant 
- Loop diuretic 
(Lasix) 
-  proton pump 
inhibitors PPI 
- Breast cancer drug 
- Prostate cancer 
drug 
- Oral contraceptive 
 
 
Low Bone Mass Density 
 
Osteoporosis 
Socio economic 
factors 
Life style factors Medical risk factors Medication use 
factors 
13 
 
2.2 LiteratureReview 
2.2.1 OsteoporosisDefinition 
Osteoporosis is a disease characterized by low bone mass, micro architectural deterioration 
of bone tissue, and a consequent increase in fracture risk (NOF, 2002).The word 
osteoporosis literally means porous bone that is bone density is low and bone become 
thinner.  
The World Health Organization define osteoporosis asa bone density 2.5 standard 
deviations below the mean for young white adult women at lumbar spine, femoral neck or 
forearm (WHO, 1994). Thereby, WHO, (1994) criteria defined osteoporosis operationally 
on the basis of bone mineral density (BMD) assessment, and divided it into four 
categories: 
 Normal (T-score -1.0 and above) 
 Low bone mass, referred to as osteopenia (T-score between -1.0 and -2.5) 
 Osteoporosis (T-score -2.5 and below) 
 Severe osteoporosis (T-score -2.5 and below with history of a fracture) (WHO, 
1994). 
Therefore, other way for measuring osteoporosis wasthe revised assessment in (2008) 
called FRAX (Fracture Risk Assessment Tool) includes BMD with selected risk factors for 
fracture along with height and weight. FRAX is calculated to determine 10-year 
probability of fracture. Two scores are given, probability of hip fracture and the other for a 
major osteoporotic fracture, defined as wrist, shoulder, hip, or painful spine fractures 
(Kanis et al., 2008). 
2.2.2 What is Bone? 
A report of the Surgeon General of Osteoporosis, recognize bone as a living and growing 
tissue in which normal bone consists of two layers, cortical bone and trabecular bone. 
Cortical bone forms the outer layer and is dense and compact, while trabecular bone has a 
honeycomb structure and is much more porous. Cortical bone provides one-third of total 
skeletal surface and three-fourths of skeletal mass. On the other hand, trabecular bone 
provides two-thirds of total skeletal surface but only one-fourth of skeletal mass(U.S. 
Department of Health and Human Service, 2004). 
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2.2.3 Beak Bone Mass 
Khosla and Riggs. (2005) define beak bone mass, as the maximum mass, accumulated 
during young adult life that is responsible for the strength of the bone is influence by 
genetic factor, nutrition, endocrine status, physical activity and health during growth 
(Khosla and Riggs, 2005). 
According to Report of Surgeon, (2004) normal bone is composed of a mixture of calcium 
and other minerals such as magnesium and phosphate. It is also made up of collagen 
(protein), which forms the structural framework of bone. Thereby the loss of mineral 
content of the bone is referred to as a loss of bone mineral density in the bone. Maximum 
Peak bone mass is reached between 16 and 25 years of age (U.S. Department of Health and 
Human Service, 2004).According to National Osteoporosis Foundation, bone mass in older 
adults equals the peak bone mass achieved by age 18-25 years minus the amount of bone 
subsequently lost (NOF, 2010). 
National Institute of Health (NIH). (2001), mention that during childhood and adolescence, 
much more bone deposited than withdrawn, so the skeleton grows in both size and density 
and by age, 18 in girls and 20 for boys they acquire up to 90 percent of peak bone mass. 
The amount of bone tissue can keep growing until around age 30. At that point, bones have 
reached their maximum strength and density, known as peak bone mass (NIH, 2001)  
Despite of women tend to experience minimal change in total bone mass between age 30 
and menopause, most women go through rapid bone loss from the bone bank account, 
which continues throughout the postmenopausal years. This loss of bone mass can lead to 
osteoporosis (Panel, 2001). 
2.2.4 Bone Modeling and Remodeling 
Throughout life, bone is constantly renew in a process called remodeling. According to 
Martin and Seeman. (2008), the remodeling process is complex and includes two main 
types of cells, osteoclasts and osteoblasts. However, Bonemodelling prevents the 
occurrence of damage by adapting bone structure and strength but bone remodeling 
removes damage in order to maintain bone strength. Despite this process successful taken 
place during growth, it fails during advancing age because of the development of a 
negative balance between the volumes of bone resorbed and formed during remodeling by 
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the basic multicellular units (BMUs), the small island in which this process occur (Martin 
and Seeman, 2008). 
Concerning A Report of the Surgeon Generalfor Bone Health and Osteoporosis,      (2004) 
the two main types of bone cell required for modeling and remodeling process are. 
Osteoclasts: are bone-chewing cells that remove old bone and get the bone ready for 
renewal. Osteoclasts release enzymes and acids that carve bones. In this process calcium, 
phosphorus, and other components of the bone are release into the blood for use by the 
body. After the osteoclasts carve the bone, it is prepared for action by the osteoblasts.  
Osteoblasts: are the building cells that form bone. Bone building occurs when bone is 
more formed than removed. Bone mass is maintained when bone formation equals bone 
removal conversely, bone loss occurs when more bone is removed than formed. 
Deterioration of bone exist either when taken diet low in calcium and vitamin D which is 
necessary for body to use calcium then  body will withdraw the calcium it needs from bone 
bank or by certain medication and medical condition (U.S. Department of Health and 
Human Service, 2004). 
2.2.5 Epidemiology of Osteoporosis 
There are a consensus in the literatures that as the world population life expectancy 
increase the incidence and prevalence of osteoporosis, and its economic burden on society 
increase. Dhanwal et al. (2011), recognize that hip fracture is the most serious consequence 
of osteoporosis because of its complications, which include chronic pain, disability, 
diminished quality of life, and premature death (Dhanwal et al., 2011).A Study suggest that 
with rising life expectancy throughout the globe, the number of elderly individuals is 
increasing in every geographical region, and it is estimated that the incidence of hip 
fracture will rise from 1.66 million in 1990 to 6.26 million by 2050  (Cooper et al., 1992).  
Johnell et al. (1992) mentioned that Studies over the last few decades have demonstrated 
geographic variation in the incidence of hip fracture across continents as well as among 
different parts of a region. Incidence of hip fracture is highest in Sweden and North 
America, with almost seven-fold lower rates in Southern European countries (Johnel et al., 
1992). Furthermore, as three quarters of the world population, live in Asia Cooper et al. 
(1992) estimated that by 2050 more than 50% of all osteoporotic fractures will occur in 
Asia (Cooper et al, 1992). This variation in the distribution of hip fracture over different 
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regions of the world demonstrate that genetic and environmental factors play a role in the 
etiology of hip fracture 
 
2.2.5.1 Prevalence and Burden of Osteoporosis in Developed Country 
 
Osteoporosis is a public health problem worldwide; statistics show that osteoporosis causes 
about 9 million fractures annually worldwide, of which more than 4.5 million occur in the 
Americas and Europe (WHO, 2010). 
 
Concerning WHO, (2004), a study for Assessment of osteoporosis at the primary health 
care level show that in the United States, Europe and Japan, osteoporosis affects about 75 
million people. By Using the WHO criteria, 30% of postmenopausal Caucasian women 
have osteoporosis at the hip, lumbar spine or distal forearm and by the age of 80 years, 
70% of women are osteoporotic at the hip, lumbar spine or distal forearm (WHO, 2004). 
Moreover, National Osteoporosis Foundation, (2002) mentioned that there were 8 million 
osteoporotic women and 2 million osteoporotic men in the United States alone (NOF, 
2002). 
 
The highest incidence of hip fractures from Asia has been reported from Singapore a study 
carried out by Kohet al. (2001) revealed that hip fracture rates from 1991 to 1998 (per 100 
000) were 152 in men and 402 in women; this was respectively 1.5 and 5 times higher than 
corresponding rates in 1960s (Koh et al., 2001).  
 
Concerning examined by ethnicity,Dhanwal et al. (2011) mention that,  since 1960, the 
main increase in hip fracture rates has been seen in Chinese and Malays, while the rates in  
Indian ethnic group appear to have decreased. The factors responsible for these racial 
differences include differences in the demographic profile, body weight, physical activity, 
prevalence of cigarette smoking and alcohol consumption, calcium intake, and frequency 
of falls in the community in elderly (Dhanwal et al., 2011). 
On the other hand men contributes 20 to 30% of all osteoporotic fractures and this 
proportion is expected to increase, Eiben et al. (2005) is estimated that in 2025, the number 
of hip fractures occurring worldwide in men will be similar to that observed in 1990 in 
women (Eiben et al., 2005). 
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2.2.5.2 Prevalence and Burden of Osteoporosis in Middle East and Africa 
While Hip fracture rates are available from many countries across Asia there is insufficient 
information about incidence and prevalence of osteoporosis among people in Middle East 
and Africa.Handa et al.( 2014) recognize in a review onprevalence of osteoporosis in 
developing countries resultthat osteoporosis presents a huge challenge in developing 
countries due to demographic evolution and aging of the population coupled with limited 
resources. The exact disease burden is difficult to enumerate because of the lack of data. 
Civilization affects bone density; as well, as fracture risk. Vitamin D deficiency is common 
even in sunny countries (Handa et al., 2014). 
 Furthermore, the prevalence of osteoporosis in less developed and developing countries is 
not clear because of few studies in these populations. However, racial differences in 
BMDare well-recognized(Handa et al., 2008). 
According tothe 2011 Audit on the Epidemiology, Costs and Burden of Osteoporosis in 
Middle East and Africa report, demonstrate that there is an extreme lack of solid 
epidemiological data throughout the region but high fracture rate throughout the region and 
major increase predicted by 2050. Nevertheless,Iran accounts for 0.85% of the global 
burden of hip fractures and 12.4% of the burden of hip fractures in the Middle East 
(Ahmadi- Abhari et al., 2007). Furthermore, Cankurtaranet al. (2005) mention that 
Osteoporosis in Turkey is extremely common nearly 65% of men and women 65 years old 
or older have osteoporosis (Cankurtaran et al., 2005).  In Morocco, El Maghraouiet al. 
(2006), is estimated that there are more than 1.5 million vertebral fractures  nearly 50% of 
all postmenopausal women have vertebral fractures, and 60% of women with fractures 
have at least two fractures (El Maghraoui et al., 2009). 
Mortality rates post-hip fracture may be higher in Middle East and Africa than those 
reported from western populations. While such rates vary between 25-35 % in western 
populations, they are 2-3 fold higher in populations from this region(Baddoura et al., 
2011). Furthermore, the International Osteoporosis Foundation (IOF) report considers 
osteoporosis a neglected disease in the Middle East, demographic and socioeconomic 
changes in the region have contributed to the rise of this disease and its burden on the 
populations and healthcare systems. Unfortunately, the report explore that the level of 
awareness among health care professionals is poor in many developing countries, and they 
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are in general ill equipped to take care of patients with osteoporosis in many countries (El-
Hajj Fuleihan et al., 2011). 
In Palestine, International Osteoporosis Foundation report, consider that osteoporosis is not 
a health priority yet due to the poor socioeconomic status and the abundance of other 
health problem, faced Palestinian population as non-communicable disease let osteoporosis 
has not priority by neither MOH nor UNRWA. There is no epidemiological study 
norstatistical evidence regarding incidence of major osteoporotic fractures. The Palestinian 
Osteoporosis Prevention Society (POPS) conducted a study on the prevalence of 
osteoporosis among postmenopausal women published in May 2010and it was found that 
around 40% of postmenopausal women were affected andmore than 50% of the studied 
population wereosteopenic at age 60-69 years. In addition, direct hospital costs for hip 
fractures are USD 3500- 4500 (Abd-Alhameed et al., 2010).   
There is a debate on whether the incidence of fractures increase by the time or 
decreaseIcks et al. (2008); Hagino et al. (2009) mentioned that despite the trend for 
increased age-adjusted incidence of fragility fractures has changed over the last 10 years 
the age-specific incidence of osteoporotic fractures mainly hip fractures continues to 
increase in some countries (Icks et al, 2008; Hagino et al, 2009). Nevertheless, in other 
countries, it is slightly decreased (Abrahamsen and Vestergaard, 2009). 
Szulc and Bouxsein. (2011) attributes this phenomenon due to several factors: 
 As life expectancy increases, at a given age an individual may be healthier. 
 Higher prevalence of obesity and lower tobacco smoking habits improve the 
maintenance of bone mass and greater use of anti-osteoporotic treatment may 
decrease the number of osteoporotic fractures.  
This recent reduction in age-adjusted incidence of fractures has only been observed in 
Western societies and the greatest increase in the number of osteoporotic fractures can be 
expected in Middle East, Asia, and Latin America, where the life expectancy is predicted 
to increase the most in the coming decades (Szulac and Bouxsein, 2011).It is estimated 
that, in these regions, the total number of hip fractures will increase more than fivefold 
between 1990 and 2050 (Eiben et al., 2005). In addition, osteoporosis consider as a 
socioeconomic health problem that increase morbidity, mortality and cost of treatment. 
Mortality rates post-hip fracture may be higher in the Middle East than those reported from 
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western populations; they are 2-3 fold higher in populations from the Middle East and 
Africa region (Baddoura et al., 2011).  
2.2.6 Financial Burden of Osteoporosis 
On the other hand, Szulc and Bouxsein, (2011) conclude that in all middle east and Africa 
countries, osteoporotic fractures are expensive and their costs are projected to increase 
because the total number of fractures are projected to rise. The financial burden of 
osteoporotic fractures includes direct costs (hospital acute care, in-hospital rehabilitation, 
outpatient services, long term nursing care) and indirect cost (morbidity, loss of working 
days).On the other hand, some costs are difficult to quantify as deterioration of quality of 
life, and time spent by the family on the care of the patient but treatment of co-morbid 
conditions after a fracture constitutes 75% of the overall healthcare cost of osteoporotic 
fractures (Szulc and Bouxsein, 2011). 
The cost to the healthcare system associated with osteoporosis-related fractures has been 
estimated at $17 billion for 2005; hip fractures account for 14 percent of incident fractures 
and 72 percent of fracture costs. In the USA, the estimated direct cost of osteoporosis is 19 
billion in the US in 2005 and expected to increase by 50% by 2025.Furthermore, every 
year in the USA, 3.5 million hospital bed days are attributed to osteoporotic fractures and 
over 60,000 nursing home admissions are attributed to hip fractures.(Burge et al., 2007). 
Similarly in Europe, where the estimated cost of osteoporotic fractures was 36 billion euro 
in 2000 and is expected to double to 77 billion euro by 2050 (Kanis et al., 2005).It has 
been estimated by the National Osteoporosis Foundation (NOF) that in 2000 
approximately 44 million people aged 50 and over in the United States either had 
osteoporosis or were at risk of developing the disease; this number is expected to rise to 
over 61 million by the year 2020. Thereby the burden of osteoporosis on the health care 
system is estimated to be approximately $17 billion annually, accounting for about $40,000 
in total medical costs for each hip fracture (NOF, 2002). Furthermore, the cost is expected 
to rise as high as $140 billion by the year 2040 (Shuler et al., 2011). 
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2.2.7 Type of Osteoporosis 
2.2.7.1 Primary Osteoporosis 
Primary osteoporosis is the most common type of osteoporosis. It is usually age-related 
and associated with the postmenopausal decline in estrogen levels, or related to calcium 
and vitamin D insufficiency.  
Type I osteoporosis (postmenopausal osteoporosis) generally develops after menopause, 
when estrogen levels drop precipitously. These changes lead to bone loss, usually in the 
trabecular (spongy) bone inside the hard cortical bone. 
Type II osteoporosis (senile osteoporosis) typically happens in women and men after age 
70 and involves a thinning of both the trabecular (spongy) and cortical (hard) bone (NIH, 
2001). 
2.2.7.2 Secondary Osteoporosis 
Secondary osteoporosis has the same symptoms as primary osteoporosis and can occur at 
any age but it has a direct cause so called secondary osteoporosis so it may occurs because 
of having certain medical conditions, such as hyperparathyroidism, hyperthyroidism, or 
leukemia. It may also occur as a result of taking medicines known to cause bone 
breakdown, such as oral or high-dose inhaled corticosteroids (if used for more than 6 
months), too high a dose of thyroid replacement, or aromatase inhibitors (used to treat 
breast cancer). Life style also contribute to emerge of osteoporosis. (NIH, 2001). 
2.2.7.3 Rare Type of Osteoporosis 
According to National Osteoporosis Society, (Aspray et al., 2014). 
 Osteoporosis in children 
There is an unusual condition in young children called "idiopathic juvenile osteoporosis" in 
which broken bones occur following minor levels of trauma without an apparent 
underlying problem. Sometimes, osteoporosis in children occurs because of other factors 
such as use of glucocorticoid steroids, brittle bone disease (osteogenesisimperfecta) or 
because a child being immobile.  
 Osteoporosis associated with pregnancy 
This is a rare condition when bones, usually in the spine or hip, break easily during or after 
pregnancy.  
  Transient migratory osteoporosis 
This is a rare condition that can cause chronic pain and is associated with sudden loss of 
bone density, usually in a hip.  
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2.2.8 Signs and symptoms of osteoporosis 
Osteoporosis is consider a silent disease because there is no symptom appear until fracture 
occurs, but the common osteoporosis symptoms mentioned by (NIH, 2001) are:  
Fracture: A fracture is one of the most common signs of fragile bones caused by 
osteoporosis that may occurs with fall or minor movement also it can even be triggered by 
a strong sneeze or cough. 
Back or Neck Pain: Osteoporosis can cause compression fractures of the spine. These can 
be very painful because the collapsed vertebrae may pinch the nerves that radiate out from 
the spinal cord. The pain symptoms can range from minor tenderness to debilitating pain. 
Loss of Height: It is one of the most noticeable symptoms of osteoporosis also; the 
compression fractures in the spine can also cause a loss of height.  
Stooped Posture: The compression of the vertebrae may also cause a slight curving of the 
upper back. A stooped back is known as kyphosis, or more commonly as dowager’s hump. 
Kyphosis can cause back, neck pain, and even affect breathing due to extra pressure on the 
airway (NIH, 2001). 
2.2.9 Consequence of Osteoporosis 
Osteoporosis is only painful if fracture have occurred that means osteoporosis increase the 
risk of fracture because bone become thin and fragile. The main bones expose to fractures 
are wrist, hip and vertebra. Osteoporotic fractures are: 
2.2.9.1 Vertebral Fracture 
Vertebral fracture is the most common osteoporotic fracture. They may occur in the 
absence of trauma or after only minimal trauma, such as bending, lifting or turning. In 
individuals aged over 50 years, Silman et al. (1997) mention that, the prevalence of 
vertebral fracture is similar in men and women, largely due to increased presence of 
traumatic fractures in men that were incurred during their youth (Silman, et al.,1997). In 
contrast, Felsenberg, (2002)a Prospective epidemiological studies show that the incidence 
of new vertebral fractures in elderly men is half that occurring in women of the same age 
(Felsenberg et al., 2002). Moreover, vertebral fractures have a major personal and societal 
impact in terms of disutility and financial costs (Kanis et al., 2004). 
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 The clinical symptoms of vertebral fractures are back pain, limitation of spine mobility, 
loss of height and disability. There is consensus in the literature that vertebral fracture can 
be associated with difficulty in bending, rising, dressing, climbing stairs, as well as 
reduced space of walking, reduced independence or even the need to use a walking aid. 
Furthermore, Silverman, et al. (2001) mention that back pain, disability and difficulties in 
performing activities of daily living are observed mainly in patients with fractures in lower 
thoracic and lumbar spine, whereas fractures in the mid-thoracic spine can result in a mild 
reduction of pulmonary function (Silverman et al., 2001). 
In addition, Kado et al. (1999) ؛Cauley et al. (2000) epidemiological studies report a higher 
mortality in patients with osteoporotic vertebral fractures, with age-adjusted mortality rates 
increasing with the number of vertebral fractures. In the working population, medical costs 
associated with vertebral fractures are related to outpatient care and to the loss of working 
days (Kado, et al., 1999;Cauley, et al., 2000). 
However, International Osteoporosis Foundation (IOF), mention that, despite major 
personal and societal impact of vertebral fractures often do not come to clinical attention 
due to two main reasons: 
 Firstly, about two thirds of vertebral fractures do not have clinical symptoms, which 
means that may confused with osteoarthritis, and may be only detected on a radiograph. 
Secondly, even on spine radiographs, vertebral fractures are often undiagnosed. Vertebral 
fractures increase the risk of new vertebral fracture four to five-fold and the risk of other 
fragility fractures two- to four-fold(Szulc and Bouxsein, 2011). 
2.2.9.2 Hip Fracture 
Hip fracture is one of the most disastrous consequences of osteoporosis. There are many 
risk factors for hip fracture but the two main attributable factors are low BMD that increase 
with age and increase risk of fall. Other factors such as lack of physical activity, poor 
nutrition, tobacco smoking, chronic alcoholism, gastrectomy, certain diseases, and some 
medications (mainly glucocorticoids, loop diuretics and thyroid hormones) (Cosman et al., 
2014).  
Cawthon et al.(2008) consider the risk of falls also increases with age, especially in the 
frail elderly with compromised neuromuscular function, poor physical performance, visual 
impairment, or insulin-treated diabetes (Cawthon et al., 2008).The impact of the fall 
depends on its direction and on the thickness of tissues surrounding the upper part of femur 
(Bouxsein et al., 2007). No doubt, aging is associated with both decrease in BMD and with 
an increased risk of falls but also poor nutrition, vitamin D and calcium deficit as well as 
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protein deficiency are common in the elderly and contribute to bone loss that results in a 
higher risk of falls and poor protective mechanisms. There are an agreement in the 
literature that Mortality is increased 15 to 25% in the year following hip fracture, with 
particularly high rates in men (Bliuc et al., 2009). 
Furthermore, Berry  et al. (2007) mention that a substantial number of people with hip 
fracture experience a second hip fracture which is characterized by higher mortality than 
the first fracture (Berry et al., 2007). The cost of hip fracture is high and includes 
hospitalization, surgical treatment and rehabilitation as well as the costs of outpatient care, 
particularly institutionalization. 
2.2.9.3 Non-Hip Non-Spine Fracture 
Fracture of the distal radius is one of the most frequent osteoporotic fractures in women 
and one of the earliest manifestations of osteoporosis. Baron  et al. (1996) consider that 
distal radius fracture incidence increases in the early postmenopausal years and then 
stabilizes while in men, the incidence of distal radius fractures increases with age only 
slightly and remains low throughout life therefore in elderly men, the incidence is four 
times lower compared with women of the same age (Baron et al., 1996). 
There are many studies mention that risk factors for this fracture in postmenopausal 
women are advancing age, an early menopause, low BMD, low BMI, falls (mainly falling 
forward on the hand), prevalent fragility fractures, height loss (often due to vertebral 
fractures), and a history of parental osteoporotic fractures. Fracture of the distal radius 
rarely requires hospitalization. However, it is associated with a temporary decrease in 
independence, deterioration in quality of life and, in working people, loss of working days 
(Delmas et al., 2007). 
On the other hand, Fracture of the proximal humerus is common in osteoporotic patients 
after 50 years of age, its incidence increases with age in both men and women (Nguyen et 
al., 2001). Similarly, to other fragility fractures, the two main risk factors for fracture of the 
proximal humerus are low BMD, mainly at the distal forearm, increased risk of falls and 
prevalent fragility fracture. Proximal humerus fracture results in a temporary loss of 
independence, deterioration in the quality of life, increased risk of hip fracture and 
increased mortality (Bliuc et al., 2009). 
Other common sites for fragility fractures include the ribs, pelvis, clavicle, femur and tibia. 
These fractures are important for two principal reasons according to Delmas et al. (2007) 
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study. Firstly, they may be the first manifestation of osteoporosis and associated increased 
bone fragility. Secondly, they may have important personal and societal consequences 
(Delmas et al., 2007). 
2.2.10 Diagnosis of Osteoporosis 
According to Szulc and Bouxsein, (2011), different diagnostic criteria of osteoporosis are: 
 Dual-energy X-ray absorptiometry (DEXA). 
  Quantitative computed tomography (QCT). 
 High-resolution peripheral quantitative computed tomography (hr-pQCT). 
  Magnetic resonance imaging (MRI). 
 Quantitative ultrasound (QUS). 
  Bone turnover markers. 
Routine X-rays can detect osteoporotic bones only when at least 30% of their bone mass 
has been lost.  At this stage of the disease, the affected bones have a much lighter and 
thinner appearance than normal bones.  An earlier and more accurate assessment of bone 
loss is accomplished through the use of bone densitometry.  Bone densitometers measure 
the absorption of radiation by the skeleton (skeletal calcium) in order to determine bone 
mass.  Measurements of bone mass are generally considered the most valid estimator of an 
individual’s fracture risk. SO, Osteoporosis is usually diagnosed using a procedure called 
dual energy x-ray absorptiometry (DXA). DXA measures areal bone mineral density 
(BMD) that is the amount of mineral in a given area of bone. The sites of measurement for 
diagnostic purposes are the lumbar spine and the hip. A DXA scan provides an indication 
of a person’s BMD in relation to normal, healthy values for a male or female of a particular 
age. It is a painless procedure, which requires the person to lie on a couch for 5-10 minutes 
while the scanner moves above the body(Szulc and Bouxsein, 2011). 
2.2.11 Men and Osteoporosis 
Many people believe that osteoporosis is a disease that affects only women.  However, this 
is not true. The NOF reports mentioned that the occurrence of osteoporosis in men has 
been greatly underestimated. It was thought that one in eight men would suffer an 
osteoporotic fracture in their lifetime however; new studies report that the risk has risen to 
one in four men (NOF, 2002).  This underestimation could be due to the fact that men have 
greater bone mass and present with osteoporotic fractures up to ten years later than women. 
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A study done by Kiebzak et al.(2002) reported that only 7% of male subjects suffering 
from a hip fracture were previously diagnosed with osteoporosis and less than 5% were 
being treated for osteoporosis upon discharge. This is alarming due to the fact that nearly 
30% of hip fractures occur in males and they are twice as likely to die after a hip fracture.  
These numbers emphasize the importance of the need for increased education and 
awareness regarding the risk of osteoporosis in men (Kiebzak et al., 2002) 
2.2.12 Risk Assessment of Osteoporosis 
The National Osteoporosis Foundation guide mention that all postmenopausal women and 
men, age 50 and older should be evaluated clinically for osteoporosis risk in order to 
determine the need for BMD testing. In general, NOF, (2002) revealed that bone density 
testing is recommended for: 
 All women age 65 or older 
 Women under age 65 with one or more risk factors for osteoporosis 
 All men over age 70 
 Men ages 50 - 70 with one or more risk factors for osteoporosis. 
Osteoporosis is preventable and treatable, but because there are no warning signs prior to a 
fracture, many people are not being diagnosed in time to receive effective therapy during 
the early phase of the disease. Many factors have been associated with an increased risk of 
osteoporosis-related fracture (Watts et al., 2008) 
2.2.13 Osteoporosis Risk Factors 
Nationalosteoporosis foundation, (2002) and many medical journal determine the risk 
factors that are clinically significant and most frequently associated with an increase the 
risk of osteoporosis. In this study, the researcher selected the most suitable risk and 
classified as socio-demographic, life style, medical, and medication factors. 
2.2.13.1 Socio-Demographic Factors 
Theselectedsocio-demographic factors in our study, which may influence the incidence of 
osteoporosis, include education, income, marital status and occupation.  
Education level 
Education is one of the most commonly used measures of socioeconomic status (SES) in 
epidemiological studies (Winkleby et al., 1992). A study carried out by Maddah, et al, 
(2011) conclude that that post-menopausal women with low education were more likely to 
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have osteoporosis than high educated women and it was approximately five times more 
than high educated women (Maddah et al., 2011). This finding is concur with the findings 
of western countries indicating that low educated women are more prone to low density 
bone and osteoporosis than high educated women (Leslie et al.,2007; Brennan  et al., 
2011). 
Woo et al.(1999) have reported that a higher level of education is associated with a 
healthier diet and lower cardiovascular risk(Woo et al., 1999). However, inconsistent 
findings between educational level and osteoporosis have been noted (Lauderdale et al., 
2001). 
In better-educated individuals might tend to have better health knowledge and behavior 
indeveloped countries and regions. On the other hand, increasing affluence and education 
in developing regions might lead to better nutrition(Brecher et al., 2002). 
Income 
 There are a debate in the literature about the effect of poverty on emerging 
osteoporosis.Poverty has been shown to be a definite risk factor for osteoporotic fractures 
in a study performed in Spain(Navarro et al., 2009). Another study evaluating Canadian 
women has shown that lower income was found to correlate with a greater likelihood of 
qualifying for osteoporosis treatment, based on an assessment of the probability of hip 
fracture (Brennan et al., 2014). However, a systematic review conducted in 2009 
concluded that conflicting evidence exists regarding the relationship between osteoporotic 
fractures and levels of income and education(Brennan et al., 2009). Another systematic 
review published in 2011 identified evidence for a positive association between 
educational level and bone mineral density (BMD) only in women, but no relationship 
between income and BMD in either gender (Brennan et al., 2011). 
Marital status:  
Pregnancy- and lactation-associated osteoporosis (PLO) is a rare condition affecting 
pregnant or breastfeeding women and it is an important type of osteoporosis causing a 
significant morbidity (Smith et al., 1995). The incidence of PLO is 0.4 in 100,000 women. 
It is considered that the number of undiagnosed patients is even higher (Hellmeyer et al., 
2003). Although its etiology is unclear, the presence of PLO in first degree relatives, low 
BMI, physical inactivity, poor nutrition, insufficient calcium intake, and smoking have 
been determined as risk factors (Terzi et al., 2014). The patients present with severe low 
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back pain in the last trimester of the pregnancy or in the postpartum period or height 
decrease secondary to fragility fractures in the vertebra. However,Pregnancy and lactation 
associated osteoporosis is often confused with other causes of low back pain during 
pregnancy (Akyuz and Bayindir, 2013). 
There is no consensus about bone loss during lactation or the long-term effects of 
pregnancy and lactation on bone. Black et al., 2000; Karlsson et al., 2005 showed that 
pregnancy is associated with bone losses of approximately 3 to 5 percent at the spine and 
hip (Black et al., 2000;Karlsson et al., 2005). While other studies have found that bone 
density remains stable during this period of increased calcium, demand or declines 
significantly only at the trochanter (Kaur et al, 2003). However, women are at risk of 
pregnancy-associated osteoporosis, if they use unfractionated heparins for thromboembolic 
disorders(Barbour et al., 1994; Dahlman., 1993). 
Moreover, the strongest finding in a previous systemic review of associations between 
socioeconomic status and osteoporotic fracture was an increased risk of fracture in the 
unmarried, single, divorced, or widowed population compared to married couple (Brennan 
et al., 2009). Thus, living alone may be assumed a risk factor for osteoporotic fracture even 
though it is not included in the World Health Organization (WHO) risk assessment for 
fracture. 
Breast-feeding  
 In contrast, lactation has more consistent and profound effects on bone density that bone 
loss of 3 to 10 percent at the spine and hip are seen over three to six months of lactation. 
Bone loss is related to duration of lactation and duration of amenorrhea and is not 
prevented by calcium supplementation (Karlsson et al., 2005).National Institute of Health 
(NIH) represent that bone loss during breast-feedingmay be caused by the growing baby 
has increased need for calcium, which is drawn from the mother’s bones. The amount of 
calcium the mother needs depends on the amount of breast milk produced and how long 
breastfeeding continues. Moreover, women also may lose bone mass during breastfeeding 
because they are producing less estrogen, which is the hormone that protects bones 
(National Institute of Health-NIH, 2015). 
Okyay et al. (2013) study concluded thatwomen who had a breast-feeding period per child 
more than 1 year under age 27 was higher in osteoporosis group. In multivariate analysis, 
women who breast-feeding more than 1 year per child had the highest risk for osteoporosis 
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(odds ratio: 12.92; 95% confidence interval, 3.1-52.6) (Okyay et al., 2013). Other study 
revealed that a significant increase in the risk of osteoporosis was apparent in 
postmenopausal women with prolonged breast-feeding histories (≥24 months) (OR 2.489; 
95 % confidence interval = 1.111 to 5.578, p = 0.027) particularly in those with inadequate 
serum vitamin D levels and calcium intakes (<800 mg/day) (Yun et al., 2016). 
Abortion history 
Ozdemir et al.(2005) mention that women who had five or more abortions were found to 
have significantly lower spine BMD values compared to women who had no abortions or 
women who had one or two abortions. These findings indicate that the increased risk of 
osteoporosis is associated with the increased number of pregnancies and abortions and 
higher age at first pregnancy (Ozdemir et al., 2005). 
2.2.13.2 Life Style Risk Factors 
Risks that may have a strong influence for developing osteoporosis among people live in 
Gaza Strip attribute to life style. In this study, theresearcher mention life style risk factors, 
which include: 
Physical Activity 
According to WHO sedentary lifestyles increase all causes of mortality, double the risk of 
cardiovascular diseases, diabetes, and obesity, and increase the risks of colon cancer, high 
blood pressure, osteoporosis, lipid disorders, depression and anxiety. Moreover, 60 to 85% 
of people in the world from both developed and developing countries lead sedentary 
lifestyles, making it one of the more serious yet insufficiently addressed public health 
problems of our time. It is estimated that nearly two-thirds of children are also 
insufficiently active, with serious implications for their future health (WHO, 2002). People 
who spend a lot of time sitting have a higher risk of osteoporosis than do those who are 
more active. Any weight-bearing exercise and activities that promote balance and good 
posture are beneficial for bones. Furthermore, walking, running, jumping, dancing and 
weightlifting seem particularly helpful (Heyward & Gibson., 2014). 
Body Mass Index (BMI) 
BMI is a person's weight in kilograms divided by the square of height in meters(Samz, 
2009).BMI Categories according to WHO were, 
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Body mass index (BMI) Weight status 
Below 18.5 Under weight 
18.5 - 24.9 Normal 
25 – 29.9 Over weight 
30 – 39.9 Obese 
Above 40 extreme obesity 
 
BMI below 19 is considered underweight and a risk factor for osteoporosis. Osteoporosis is 
more common in people who have a small, thin body frame and bone structure. Low body 
weight (less than 58 kg) is associated with increased risk of osteoporosis and fractures, 
possibly related to small bone size (Green et al., 2004). Weight loss after age 50 years in 
women and decreased height also raise the risk of hip fracture, while weight gain decreases 
it (Ensrud et al., 2003). The mechanism of weight loss may influence the effect on bone 
physiology. In one small, randomized trial, done by Villareal  et al, (2006) mentioned that 
subjects who lost weight by calorie restriction had decreases in total hip BMD, whereas 
subjects who lost the same amount of weight via exercise without reduced caloric intake 
had no changes in BMD (Villareal et al., 2006). A study done by Asomaning et al. (2006) 
explore that BMI was inversely associated with BMD status. After adjustment for age, 
prior hormone replacement therapy use, and other factors, odds ratios (OR) for low, high, 
and obese compared with moderate BMI women were 1.8 (95% CI 1.2-2.7), 0.46 (95% CI 
0.29- 0.71), and 0.22 (95% CI 0.14-0.36), respectively, with a significant linear trend (p < 
0.0001) across BMI categories (Asomaning et al., 2006). 
Cigarette Smoking 
Smoking also increases the risk of osteoporotic fractures. Studies of nearly 60,000 people 
in Canada, U.S.A., Europe, Australia and Japan show that smoking increases the risk of hip 
fracture by up to 1.5 times. Although the risk of fracture from smoking increases with age, 
cigarette smoke has an early effect on bones(Kanis et al., 2005). Studies carried out in 
Sweden showed that young male smokers, 18-20 years old, have reduced bone mineral 
density and an increased risk of osteoporosis later in life (Gregg et al., 2000). 
Furthermore, meta-analyses have shown that cigarette smoking is associated with reduced 
BMD and increased risk of fracture The risk of fracture was increased with a smoking 
history and current smoking, but was higher for current smokers(Tamaki et al., 2011).A 
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study in the United States revealed that a high proportion of women were unaware of the 
association between cigarette smoking and osteoporosis(Roth and Taylor, 2001). 
Milk and Dairy Consumption 
Matthews et al. (2011) mentioned thatwomen whose dairy intake was once a day or more 
had a 62% reduction in the likelihood of having osteoporosis (OR=0.38, 95%CI: 0.17–
0.86, p value 0.02) compared to women whose dairy intake was less than twice a week. 
Among individual dairy products, only cheese showed an independent and significant 
protection (OR=0.28, 95%CI: 0.12–0.66, p value 0.004) for women eating cheese more 
than once per week compared to those who ate cheese less than once a week. In contrast, a 
2005 review published in Pediatrics showed that milk consumption does not improve bone 
integrity in children (Lanou et al., 2005). Similarly, the Harvard Nurses’ Health Study, 
which followed more than 72,000 women for 18 years, showed no protective effect of 
increased milk consumption on fracture risk   (Feskanich et al., 2003).          
Low Calcium and Vitamin D Intake 
Calcium is essential for building strong bones while vitamin D helps the body to absorb 
calcium both of them are needed to prevent developing of osteoporosis. Our bodies 
produce vitamin D when the skin is exposed to sunlight. There is a consensus in the 
literature indicate that Low calcium and vitamin D intake contributes to diminished bone 
density, early bone loss and an increased risk of fractures. Unfortunately, 90% of women 
may not be getting enough calcium and over 50% of women treated for bone loss have 
inadequate vitamin D levels (Holick et al., 2005; Sunyecz, 2008). The US Surgeon General 
report has outlined a ‘pyramid approach’ to treating bone diseases. Prevention of falls with 
maintenance of bone health through adequate calcium, vitamin D, and physical activity 
represent the base of the pyramid for all individuals, including those with bone disease. The 
second tier of this pyramid relates to identifying and treating secondary causes of 
osteoporosis. Lastly, the third tier revolves around pharmacotherapy (US Department of 
Health And Human Service, 2004). 
 A study done by Tang et al. (2007) concluded that calcium, or calcium in combination 
with vitamin D supplementation, was effective in the preventive treatment of osteoporosis 
in people aged 50 years or older. It appeared that the best effect was seen with minimum 
doses of 1200 mg of calcium and 800 units of vitamin D daily (Tang et al., 2007).Other 
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meta-analysis study mentioned that using vitamin D dose of 700 to 800 units per day result 
in reduced the relative risk of hip fracture by 26% and any non-vertebral fracture by 23% 
(Bischoff-Ferrari et al., 2005). Subsequently, an enhanced meta-analysis was done to 
define the need for additional calcium supplementation in individuals receiving vitamin D 
for the prevention of hip fractures the findings suggested that oral vitamin D appears to 
reduce the risk of hip fractures only when calcium supplementation is added (Boonen et 
al., 2007). 
The Recommended dietary intake of calcium and vitamin D. 
Source: (Sunyecz, 2008) 
Caffeine and soft drink intake 
Coffee, tea and soft drinks (sodas) contain caffeine, which may decrease calcium 
absorption and contribute to bone loss. NOF recommend that drinking more than three 
cups of coffee every day may interfere with calcium absorption and cause bone loss. A 
study carried out by Hallstorm et al. (2006) indicate that a daily intake of 330 mg of 
caffeine, equivalent to 4 cups (600 ml) of coffee, or more may be associated with a 
modestly increased risk of osteoporotic fractures, especially in women with a low intake of 
calcium (Hallström et al., 2006). 
Some expert mention that there is an association between people who have high soda 
intake and risk of fracture, that is probably due to the fact that if they have a high soda 
intake, they have a low milk intake. Furthermore, NOF notified that certain soft drinks and 
sodas, especially colas, contain phosphorous in the form of phosphoric acid and caffeine. 
However, Colas may have other chemicals, besides phosphoric acid and caffeine that can 
affect the bones. People with osteoporosis should not drink more than five cola drinks a 
week (NOF, 2002). 
Age (years) Calcium (mg/day) Vitamin D (IU/day) 
4–8 800 200 
9–13 1300 200 
14–18 1300 200 
19–30 1000 200 
31–50 1000 200 
51–70 1200 400 
≥70 1200 600 
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Additionally National Osteoporosis Foundationrecommended that for bone health, it is best 
not to drink too many soft drinks or cups of coffee every day. To maintain bone healthfor 
adults under age 50 get 1,000 mg of calcium every day, and adults age 50 and older get 
1,200 mg of calcium every day. 
Using Aluminum Cookware: 
Aluminum cookware is cheap and widely available and it has a negative consequence for 
health.A study published in the International Journal of Electrochemical Science has 
discovered that cooking with aluminum increases the risk of developing Osteoporosis and 
alzehaimers disease(Bassioni,et al., 2012). In addition, Asiedu-Gyekye et al. (2016) study 
explore thathigh aluminum levels in the body alter bone mineralization, matrix formation, 
as well as parathyroid and bone cell activity. Ironically, one of the most common signs of 
excessive aluminum accumulation is hypercalcemia or high calcium levels in the 
blood.This happens because the presence of aluminum impedes calcium deposition in 
bone, thus leading to elevated blood calcium levels. As a result, parathyroid hormone 
(PTH) secretion, the hormone secreted by the parathyroid hormone, is greatly depressed. 
Additionally, chronic aluminum toxicity greatly reduces osteoblast population and inhibits 
bone mineralization, resulting in osteoporosis (Asiedu-Gyekye, et al., 2016). 
Sunlight Exposure 
Our skin makes vitamin D from the ultra-violet light in sunlight. Ourbodies store the 
vitamin and use it later. The amount of vitamin D in skin makes depends on time of day, 
season, latitude, skin pigmentation and other factors. Depending on where you live, 
vitamin D production may decrease or be completely absent during the winter.Because of 
concerns about skin cancer, many people stay out of the sun, cover up with clothing and 
use either sunscreen or sunblock to protect their skin. The use of sunscreen or sunblock is 
probably the most important factor that limits the ability of the skin to make vitamin D. 
Because of the cancer risk from the sun, most people need to get vitamin D from other 
sources, including eating foods rich in vitamin D and taking vitamin D supplements (NOF, 
2002). 
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2.2.13.3 Medical History of Disease 
Many medical diseases are associated with low BMD and increased risk of fracture, due to 
underlying inflammation, malabsorption, renal excretion of calcium, or medications used 
to treat the diseases. The researcher select the most known and spread condition. 
Rheumatoid arthritis (RA) 
Osteoporosis of the hip or lumbar spine is common in adults with RA. This was illustrated 
in a study of 287 Norwegian patients among whom the prevalence of osteoporosis, as 
indicated by a bone mineral density of more than 2.5 standard deviations below the 
average for healthy young people at one or both sites, was 22 percent (Haugeberg et al., 
2002). Other study recognize that patients with RA have a 30 percent increased risk of 
major osteoporotic fracture and 40 percent increased risk of hip fracture (Kanis, 2008). 
Hyperthyroidism 
According to National Osteoporosis Society, bone is continuously being broken down and 
replaced by cells known as osteoclasts and osteoblasts where each cycle of bone ‘turnover’ 
takes about 200 days and excess thyroid hormone will hasten this rate of bone turnover. 
However, if thyroid hormone levels stay too high for too long, there is an increased risk of 
developing low bone density and osteoporosis, particularly post-menopausal woman. 
Moreover, hyperthyroidism can also be associated with muscle weakness and loss of lean 
body mass, which can be quite severe in some cases. This can then lead to an increased 
risk of falling and subsequent broken bone (Aspray et al., 2014). In a population-based 
study of 17,684 individuals taking thyroxin in  Scotland, there was no increase in 
osteoporotic fractures in the 3731 individuals whose thyroid stimulating hormone(TSH) 
was low but detectable (between 0.04 and 0.4 mU/L), while those with undetectable TSH 
(below 0.03 mU/L) had a twofold increased risk (Flynn et al., 2010). 
Hyperparathyroidism 
In primary hyperparathyroidism, the diseased gland makes too much parathyroid hormone 
(PTH), which in turn causes an increased breakdown of normal bone. As the bone breaks 
down, the bone density decreases which in turn increases the risk of fractures or broken 
bones (Mechanick et al., 2013). Women are three times more often affected by primary 
hyperparathyroidism than men, and its incidence is as high as 1:500 in elderly women in 
which consider a high-risk population for osteoporosis. Furthermore, either osteoporotic 
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fractures or a T scores of <−2.5 is an indication for parathyroid surgery in otherwise 
asymptomatic patients (Bilezikian et al., 2009).A recent observational study over the 
course of 15 years showed that parathyroidectomy normalized biochemical indices of bone 
turnover and preserved BMD, whereas cortical bone density decreased in the majority of 
subjects without surgery during long-term follow-up (Rubin et al., 2008). 
Menstrual history for female 
According to North American Menopause Society,(2007)premature menopause refers to 
menopause that occurs before age 40 years, and early menopause refers to menopause that 
occurs at or before age 45 years, both ranges being well below the median age of natural 
menopause age 51 years. Menopause is a major risk factor for osteoporosis where the 
incidence of fractures increases by about 40% with menopause in developing countries 
(Sadat-Ali et al., 2004). The relationship between osteoporosis and hypertension can be 
understood through menopause, the underlying mechanism is through hormonal changes as 
part of the aging process and the accompanying reduction in estrogen and progesterone(El-
Heis et al., 2013). 
Having both ovaries removed before age 45 is strongly associated with low-bone mineral 
density and arthritis in later years, according to a new study by Johns Hopkins oncologists 
and epidemiologists, (2011). 
Diabetes Mellitus 
Patients with diabetes typically have low bone turnover with reduction in bone formation 
and, to a lesser degree, bone resorption.Insulin, which is deficient in type 1 diabetes, may 
promote bone growth and strength. The onset of type 1 diabetes typically occurs at a young 
age when bone mass is still increasing. So, it is possible that people with type 1 diabetes 
achieve lower peak bone mass, the maximum strength and density that bones reach(Urs 
and Rosen, 2012).  
A study explore that Diabetes mellitus (DM) is associated with increased incidence of 
osteoporosis fractures via visual impairments resulting from diabetic retinopathy and 
cataract (Wongdee and Charoenphandhu, 2011). Other study mention that the risk of 
osteoporotic fractures is increased by 12-fold in patients with type 1 diabetes(Nicodemus 
and Folsom, 2001). Furthermore, Hofbauer et al.(2007) concluded that diabetic 
complications such as retinopathy, polyneuropathy, and nephropathy, are the major 
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determinants of low bone mass and increased fracture risk, in part due to the enhanced 
propensity of falls (Hofbauer et al., 2007). 
On the other hand, National Institute of Health NIH mentioned thatincreased body weight 
could reduce one’s risk of developing osteoporosis. Since excessive weight is common in 
people with type 2 diabetes, affected people were long believed to be protected against 
osteoporosis. However, although bone density is increased in people with type 2 diabetes, 
fractures are increased this may be due to increased falls because of vision problems and 
nerve damage. Moreover, the sedentary lifestyle common in many people with type 2 
diabetes also interferes with bone health(NIH, 2001). 
Data from the Women's Health Initiative Observational Study also indicate a 20% higher 
risk for fractures after adjustment for frequent falls and increased BMD (4–5% higher at 
the hip) in women with type 2 diabetes mellitus (Bonds et al., 2006).  An important 
additional risk factor for fractures in postmenopausal women with type 2 diabetes mellitus 
is the use of a thiazolidinedione(TZD) type insulin sensitizer, associated with fractures of 
the hip, humerus, and small bones of the hands and feet (Schwartz et al., 2006).A meta-
analysis of 12 studies reported a relative risk (RR) of 1.7 (95% CI: 1.3–2.2) for hip fracture 
in both men and women with TZD(Janghorbani et al., 2007). 
Personal History of Fracture:  
A history of a fragility (low-trauma) fracture is another important risk factor for 
subsequent fracture in men and women (Cauley et al., 2007; Center et al.,2007).Kanis et al, 
(2004) explore in meta-analysis of 11 prospective cohort studies of fracture risk in men or 
women with prior fracture. They reported increased risks of any fracture (relative risk [RR] 
1.8, 95% CI 1.6-1.9), osteoporotic fracture (RR 1.8, 95% CI 1.6-1.9), and hip fracture (RR 
1.6, 95% CI 1.3-2.0) in both men and women, even after adjustment for BMD (Kanis et al., 
2004). In a prospective cohort study of 4005 Australian men and women followed for 16 
years, the RR of subsequent fracture in women with any initial low-trauma fracture (after 
age 60 years) was 2.0 (95% CI 1.7-2.2) and for men was 3.5 (95% CI 2.7-4.5) (Center et 
al., 2007). 
Moreover, Mackey et al, (2007), mention that in women, a history of a high-trauma 
fracture may also be a risk factor for subsequent fracture. In a nine-year study of 8022 
women participating inStudy of Osteoporotic Fractures, women with a previous history of 
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high- and low-trauma non-spine fractures had a similarly elevated risk of subsequent 
fracture compared with women who had not had such fractures . The risk of a subsequent 
fracture was 34 percent (95% CI 7-67) and 31 percent (95% CI 20-43) greater among 
women with a history of high- and low-trauma fracture, respectively(Mackey et al., 2007). 
On the other hand, a history of premenopausal fracture significantly increases the risk of a 
postmenopausal fracture. Data from the Study of Osteoporotic Fractures demonstrate that 
women with a history of premenopausal fracture are 35 percent more likely to fracture 
during the postmenopausal years compared with women without a history of 
premenopausal fracture (Hosmer et al., 2002). 
There are many studies recognize a number of factors influence the rate and degree of 
premenopausal bone loss including age, weight changes, BMI, calcium and vitamin D 
intake, physical activity, family history of osteoporosis, smoking, and number of 
pregnancies(Macdonald et al., 2005;Leib, 2005;Uusi-Rasi et al., 2002). 
Family History of Fracture:  
In a first-degree relative parental, history of hip fracture is associated with a twofold 
increased risk of hip fracture in women, regardless of BMD (Cummings et al., 1995). A 
study of Prevalence, family history, and prevention of reported osteoporosis in U.S. 
women conclude that women with a family history of osteoporosis were:  
 2.4 times more likely to have osteoporosis than women without such history 
 8.5 times more likely to have osteoporosis when two or more relatives were 
affected, for women aged 35 years or older 
 more likely to report preventive behavior such as, taking calcium supplements, 
vitamin D, or both; increased physical activity; and estrogen use (Robitaille et al., 
2008). 
Furthermore a study done by Keen et al.(1999) showed that family history of osteoporotic 
fracture was associated with an increased total risk for osteoporotic fracture, with an odds 
ratio (95% confidence interval) of 2.02 (1.02, 3.78). Site-specific analysis showed that a 
positive family history of wrist fracture was associated with a considerably elevated risk of 
wrist fracture, with an odds ratio of 4.24 (1.44, 12.67). These increases in risk remained 
after adjustment for BMD, suggesting that other genetic factors account for the familial 
risk of osteoporosis and fracture (Keen et al,.1999).Other study from seven prospectively 
studied cohorts a parental history of fracture was associated with a modest but significantly 
increased risk of any fracture, osteoporotic fracture and hip fracture in men and women 
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combined. The risk ratio (RR) for any fracture was 1.17 (95% CI=1.07-1.28), for any 
osteoporotic fracture was 1.18 (95% CI=1.06-1.31), and for hip fracture was 1.49 (95% 
CI=1.17-1.89). The risk ratio was higher at younger ages but not significantly so. No 
significant difference in risk was seen between men and women with a parental history for 
any fracture (RR=1.17 and 1.17, respectively) or for an osteoporotic fracture (RR=1.17 and 
1.18, respectively). For hip fracture, the risk ratios were somewhat higher, but not 
significantly higher, in men than in women (RR=2.02 and 1.38, respectively). A family 
history of hip fracture in parents was associated with a significant risk both of all 
osteoporotic fracture (RR 1.54; 95CI=1.25-1.88) and of hip fracture (RR=2.27; 95% 
CI=1.47-3.49)(Kanis et al., 2004). 
Chronic Asthma 
National institute of health NIH osteoporosis and related disease mention that People with 
asthma tend to be at increased risk for osteoporosis, especially in the spine, for several 
reasons. First, anti-inflammatory medications, known as glucocorticoids, are commonly 
prescribed for asthma. When taken by mouth, or inhaled form these medications can 
decrease calcium absorbed from food, increase calcium lost from the kidneys, decrease 
bone formation, and increase bone loss. Corticosteroids also interfere with the production 
of sex hormones in both women and men, which can contribute to bone loss, and they can 
cause muscle weakness, which can increase the risk of falling and related fractures(NIH, 
2001). 
Gastro-Intestinal Tract (GIT) Problem 
Osteoporosis is common in GIT diseases, particularly those associated with malabsorption 
and maldigestion (celiac disease, postgastrectomy, short gut, pancreatic insufficiency); 
inflammatory bowel disease; Crohn's disease and ulcerative colitis). (Katz and Weinerman, 
2010). 
Furthermore, People with low weight anorexia nervosa are at special risk of  developing 
osteoporosis, and at a much younger age than people with no history of eating disorder 
(Klibanski et al., 1995; Hotta et al., 1998). Osteoporosis is less common in individuals with 
bulimia nervosa than in those with anorexia nervosa, primarily because weight history 
tends be significantly higher in bulimic individuals. Fractures are also more common in 
people with anorexia nervosa, or those with a history of the illness (Biller et al., 1989; 
Klibanski et al. 1995). 
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Washington University School of Medicine mention that celiac disease is an intestinal 
disorder caused by intolerance to wheat flour (gluten). Our results suggest that as many as 
three to four percent of patients who have osteoporosis have the bone disease as a 
consequence of having celiac disease, which makes them unable to absorb normal amounts 
of calcium and vitamin D (Washington University School Of Medicine, 2005) 
Stroke 
Loss of bone mineral density (BMD) and osteoporotic fractures, particularly of the hip, are 
common complications after stroke.Osteoporosis after stroke differs from age-related 
osteoporosis or bone loss secondary to endocrine diseases, nutritional disorders and drug-
related factors, since it is more evident on the paretic side and involving the upper 
extremities usually, more than the lower (worthen et al., 2005).  
In addition, the clinical significance of osteoporosis after stroke is that it results in skeletal 
fragility and in an increased risk of fractures, mainly of the hip (Dennis et al., 2002; 
Ramnemark et al., 1998). However, Complications from fractures lead to increased 
morbidity and mortality where the pathogenesis of osteoporosis after stroke remains 
unclear but several factors appear to have an influence on bone mass in stroke patients, 
such as the degree of paresis, gait disability and the duration of immobilization (carda et 
al., 2009). 
Cancer 
Nearly all cancers can have significant negative effects on the skeleton. Cancer is a major 
risk for both generalized and local bone loss, with bone loss as assessed by bone mineral 
density (BMD) testing substantially higher in cancer patients than in the general 
population, independent of cancer type (Reuss-Borst et al., 2012).Cancer-associated bone 
loss is the result of multiple, inter-related factors. These include both the direct effects of 
cancer cells, and the effects of therapies used in cancer treatment including 
chemotherapeutics, corticosteroids, aromatase inhibitors, and androgen deprivation 
therapy. Further, the skeleton is also the most common site of metastatic disease, as cancer 
cells growing within bone induce osteoblasts and osteoclasts to produce factors, which 
stimulate further cancer growth(Roodman, 2004). 
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Depression 
Major depression is associated with low bone mass and increased incidence of osteoporotic 
fractures. However, causality between depression and bone loss has not been established.In 
a recent meta-analysis study done by Bab and Yirmiya. (2010)comparing depressed with 
non-depressed individuals they report that BMD is lower in depressed than non-depressed 
subjects. The association between depression and BMD is stronger in women than men and 
in premenopausal than postmenopausal women. The study demonstrate a causal 
relationship between depressive-like behavior and bone loss. The depression-induced bone 
loss is associated with increases in skeletal norepinephrine and serum corticosterone levels. 
Hence, depression appears as a significant risk factor for low BMD, causing bone loss 
through stimulation of the sympathetic nervous system (Bab and Yirmiya, 2010). 
A substantial proportion of depressed patients receive antidepressants, mostly selective 
serotonin reuptake inhibitors (SSRIs). Some of these have been linked to decreased BMD 
(SSRIs) and increased fracture risk (SSRIs and tricyclic agents). Current use of SSRIs and 
tricyclics increases fracture risk by as much as twofold versus nonusers, even after 
adjustment for potential confounders (Rizzoli, et al., 2012). 
2.2.13.4 Medication Use Factors 
Drug-induced osteoporosis is a significant health problem and many physicians are 
unaware that many commonly prescribed medications contribute to significant bone loss 
and fractures.In this study the researcher, mention the most common used drug that 
literature suggest there effect on bone health. 
Glucocorticoid Therapy 
 Glucocorticoids increase bone resorption and reduce bone formation, Glucocorticoid 
therapy is associated with clear risk of bone loss, which is most pronounced in the first few 
months of use. In addition, glucocorticoids increase fracture risk, and fractures occur at 
higher bone mineral density values than occur in postmenopausal osteoporosis. 
Furthermore, it decrease intestinal calcium absorption, and increase renal calcium 
excretion(Canalis et al., 2007). A retrospective cohort study in 244,235 oral glucocorticoid 
users in the United Kingdom General Practice Research, database showed a dose-
dependent relationship between chronic glucocorticoid use and fracture risk, with high 
doses (prednisolone 7.5 mg/day or greater) having the highest risk . Low doses of 
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glucocorticoids (prednisolone less than 2.5 mg/day) were also associated with increased 
fracture risk (Van Staa et al., 2000). 
Proton Pump Inhibitors (PPI) 
PPIs appear to increase the risk of hip fracture, but not in those without preexisting fracture 
risk. Data from the Women's Health Initiative did not demonstrate an increased risk of hip 
fracture with PPI use but There was a 47% increased risk for clinical spine fracture and a 
26% increased risk for forearm or wrist fracture associated with PPI use (Gray et al., 
2010). 
Epidemiologic studies have found an increased risk of fracture with long-term PPI use (≥1 
year) (Yang et al., 2006).while the effects do not appear to be dose dependent (Pitts and 
Kearns, 2011). A large meta-analysis found that PPI but not H2-receptor antagonist use 
was associated with an increased risk of fracture (Eom et al., 2011). Another study also 
failed to find an association between PPI use and a reduction of BMD in a Manitoba 
population consisting primarily of women aged >65 years (Targownik et al., 2010). 
Mazziotti et al., (2010) consider that the risk of fracture appears to reverse 1 year after 
discontinuing the drug. A decrease in calcium absorption is thought to be the mechanism 
contributing to the increased fracture risk (Mazziotti et al., 2010). Because of the lack of 
evidence demonstrating a loss of BMD with PPI use, randomized controlled trials are 
needed to definitively prove a causal effect between PPI use and increased risk of fracture 
(Ngamruengphong et al., 2011). 
Loop Diuretics (LDs) 
There is evidence that LDs are associated with a loss of BMD. Loop diuretics increase the 
renal excretion of calcium, which can result in a hypocalcaemia state. Compensatory 
processes are thought to be responsible for the loss of bone. One study showed a 
significant increase in parathyroid hormone a few hours after a dose of bumetanide, which 
promotes bone resorption .BMD loss appears to be dose-dependent (Rejnmark et al., 
2003).A study of men aged ≥65 years using LDs demonstrated BMD loss, which also 
appeared to be dose dependent. The loss was not as great as has been observed with 
postmenopausal women. Bone loss was larger in continuous users than in intermittent 
users or nonusers (Lim et al., 2008). 
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Rejnmark et al, (2006) mention in a randomized, controlled trial of postmenopausal 
women supplementing with calcium and vitamin D, BMD loss was observed after 1 year in 
the active group (bumetanide 2 mg/day). The decrease of BMD at the hip, forearm, and 
lumbar spine was 1.6%, 2.0%, and 1.0%, respectively. After bumetanide was discontinued, 
BMD appeared to recover. Six months post treatment; there was no significant difference 
between the treatment group and the control group. Furthermore, the study concluded that 
ever use of LD was associated with a crude 51% (OR 1.51; 95% CI 1.48–1.55) increased 
risk of any fracture and a 72% (OR 1.72; 95% CI 1.64–1.81) increased risk of hip fracture. 
Use of furosemide was associated with higher risk estimates than use of 
bumetanide(Rejnmark et al., 2006) 
AnticoagulantDrug 
Unfractional heparin: A Long-term unfractionated heparin (UH) use is associated with an 
increased risk of osteoporosis, up to one-third of patients on long-term UH therapy have a 
subclinical reduction of BMD, and approximately 2% to 3% experience a symptomatic 
fracture.  Because heparin remains on the bone so reduced, BMD may not be readily 
reversible (Rajgopal et al., 2008). Vertebral fractures are most common with heparin-
induced osteoporosis. The loss of bone while using UH is time and dose dependent 
(Handschin et al., 2005). 
Low-molecular-weight heparin(LMWH): LMWH is often prescribed for 
thromboprophylaxis in pregnant women. LMWH has a more predictable clinical response, 
greater bioavailability, and possibly lower incidence of adverse effects when compared to 
UH. BMD loss may occur in pregnant women without adequate calcium and vitamin D 
intake (Casele et al., 2006). LMWH may also be associated with a lower risk of 
osteoporosis, but the evidence is conflicting. Long-term LMWHs are most often used in 
pregnant women, making clinical study difficult due to ethical issues. Some studies 
demonstrate a lower risk of bone loss with the use of LMWHs when compared to UH. 
Other studies find subclinical loss of BMD with the use of LMWHs (Wawrzyńska et al., 
2003). 
Anticonvulsant Drug 
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the majority of published studies and evidence establish that use of anticonvulsant drug 
include phenytoin (PHT), carbamazepine (CBZ), primidone (PRM), and phenobarbital 
(PB)  are associated with altered bone metabolism and decreased bone density which 
consider as inducers of the cytochrome P450 enzyme system which convert vitamin D to 
an inactive form (Verrotti et al., 2000). National osteoporosis society explore that many 
risk factors associated with anticonvulsant drug induce osteoporosis include, high dose of 
drug, multiple drug regimens ( more than one drug used), long term use and staying indoor 
with little exposure to sun light resulting in vitamin D deficiency (National osteoporosis 
Society, 2012). 
Contraceptive 
Oral contraceptives are a safe and acceptable form of contraception in perimenopausal 
women and may be effective in maintaining bone mass prior to menopause. Studies of the 
bone-sparing properties of oral contraceptives are difficult to interpret because of 
confounding variables, such as age, smoking, duration of use, exercise, menstrual function 
and endocrine diseases. Nevertheless, the results of many studies suggest that 
premenopausal use of oral contraceptives is associated with higher bone density than is 
nonuse. Long-term premenopausal oral contraceptive use allows women to enter 
menopause with bone density that is 2-3% higher than in nonusers. The optimal duration of 
use and dosage of estrogen and the clinical importance of this effect remain to be 
determine (corson, 1993).However, the long-acting progestogen injectable contraceptives 
depot medroxyprogesteroneacetate (DMPA) and norethisteroneenthate have been found to 
adversely affect bone mineral density in adult premenopausal women and adolescents. 
While Bone loss occurring with DMPA use is reversible and is not likely to be an 
important risk factor for low bone density and fractures in older women, although data on 
fracture risk in DMPA users are lacking(Kaunitz et al., 2008). 
Anti-Hypertensive Drug 
Osteoporosis and hypertension are two frequent diseases among the aging population and 
often coexist. Moreover, treatment ofhypertension affects bone mineral density and, 
therefore, can worsen osteoporosis. 
The most relevant non-genetic factors in the etiology of osteoporosis and hypertension are 
low calcium intake, vitamin D and vitamin K deﬁciency, high consumption of sodium salt, 
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and the effects of different forms of nitric oxide. Thiazide diuretics are the only 
antihypertensive that have a positive inﬂuenceon bone mineral density. For other 
antihypertensive drugs, the data are conﬂicting, indicating that they may have a potentially 
negative or positive inﬂuence on bone mineral density and fracture risk reduction. Some 
studies did not ﬁnd a correlation between the use of antihypertensive and bone mineral 
density. Due to the frequent coexistence of hypertension and osteoporosis (Ilić etal., 2013). 
Chen et al., (2016)longitudinal cohort study found that Antihypertensive drugs have been 
linked to new-onset osteoporotic fracture, and different classes of antihypertensive drugs 
may alter the risk for the development ofosteoporotic fracture. The risk of new-onset 
osteoporotic fracture after adjusting age, sex, comorbidities, and concurrent medications 
was higher among the users of angiotensin-converting enzyme (ACE) inhibitors (OR, 1.64; 
95% confidence interval [CI], 1.01–2.66) than among nonusers. Patients who took calcium 
channel blockers (CCBs) (OR, 0.70; 95% CI, 0.49–0.99) were at a lower risk of 
developing new-onset osteoporotic fracture than nonusers. Loop diuretics, thiazide 
diuretics, angiotensin receptor blocker, beta-blocker, and alpha-blocker were not associated 
with the risk ofnew-onset osteoporotic fracture (Chen et al., 2016). 
On the other hand, statistical significant differences (P value = 0.008) were observed 
between the beta-blocker and calcium channel blocker groups (Ağaçayak et al., 2014). 
2.2.14 Osteoporosis Treatment 
Several effective medicines are approved for the prevention and treatment of osteoporosis. 
These agents have been demonstrated to reduce vertebral, and in some cases non-vertebral, 
fracture risk in women with osteoporosis. They can be broadly divided into two categories:  
anti-resorptive (or anti-catabolic) or anabolic agents. Anti-resorptive agents, which include 
estrogen, the selective estrogen receptor modulator raloxifene, bisphosphonates and the 
human monoclonal antibody to receptor activator of NFκB ligand reduce bone resorption 
(and subsequently bone formation), leading to an increase in BMD to varying degrees. In 
comparison, anabolic agents, which include full-length parathyroid hormone (PTH1-84) 
and teriparatide (PTH1-34) stimulate bone formation (and subsequently bone resorption), 
thereby increasing BMD (Szulc et al., 2011). 
According to a clinical practice guideline by the American College of Physicians, because 
of the significant disability, morbidity, mortality, and expenses associated with 
osteoporotic fractures treatment aimed at fracture prevention (Qaseem et al., 
2008).Furthermore, preventive measures include modification of general lifestyle factors, 
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such as increasing weight-bearing and muscle-strengthening exercise, which have been 
linked to fractures in epidemiologic studies, and ensuring optimum calcium and vitamin D 
intake as adjunct to active anti-fracture therapy (Sandhu et al., 2011), 
A 2008 literature review suggested that the use of reminders plus education targeted to 
physicians and patients can lead to increased bone mineral density (BMD) testing and 
greater use of osteoporosis medications (Kastner et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Chapter 3 
Methodology 
These chapters illustrate the methodology use in this study. It clarify the study design, 
study population, study setting, period suggesting for study, sampling process, inclusion 
criteria and date collection. Further, it present the validity and reliability of the instrument 
that it use for data collection. Additionally, it includes method of data collection, limitation 
of the study and ethical consideration. 
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3.1 Study Design 
Thedesign of this study is case-control study with matching of three variables, gender, age 
and place of treatment. Case control study is an observational type of study in which two 
exciting groups are differs in outcome. The first group is patients who have the disease or 
outcome of interest (cases) and compare them to people who have not experience to the 
disease or outcome (controls). Case control study also known as "retrospective study" 
because it aim to determine the exposure to the risk factor of interest from each of the two 
groups' case and control. The mainly advantages of case control study are studying rare 
condition or disease, relatively inexpensive with less time as the condition or disease has 
already occurred. Additionally, it let the researcher look at multiple risk factors so establish 
an association between risk factor and disease. Thereby, it can answer questions that could 
not be answered by other study design. However, the major disadvantage of retrospective 
study is in the quality of data that rely on memory with past events so it potential for recall 
bias. Additionally, it is difficult to evaluate diagnostic tests because it is already clear that 
the cases have the condition and the controls have not. 
3.2 Study population 
The study population consists of theosteoporotic patients diagnosed during data collection 
period in which diagnosis confirm by physician measuringbone mass density (BMD) by 
DEXA scan. The researcher determined each of case and control groups as follows. The 
case group consisted of participants with osteoporosis diagnosed by physician and 
confirmed by doing DEXA scan, while control group consisted of participant matched with 
gender, age and location of treatment without history of osteoporosis confirmed by doing 
DEXA scan. For every osteoporotic patient (a case) diagnosed, a non-osteoporotic 
participantwas taken from the same center (a control) which diagnosis confirm him/her as 
osteoporosis free. 
3.3 Study Setting 
Thisstudy was conducted in the Palestinian German Diagnostic Center, which has DEXA 
scan for measuring bone mass density (BMD). For each case, control had been taken from 
the same center. 
3.4 Sampling 
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Sample defines as a subset of a population selected for measurement, observation or 
questioning, to provide statistical information about the population. Thesample size for this 
study determined by using the statistical calculator of the EPI-Info software V.20 based on 
the literature review. The sample size is 146 participant will divided into 73 cases and 73 
controls with a ratio of one case to one control at (α = 0.05, power = 0.8) matching was 
done by age, gender and location of the treatment. The researcher increased the actual 
sample size to 160 participant to compensate the missing and non-responders (annex-
2).The researcher selected each case and control during time of data collection and 
therefore after doing DEXA scan to identify participants who have osteoporosis (cases) 
and those whose are free (controls) then face-to-face interview questionnaire were done for 
each participant.The researcher used convenience sample to select the case and control 
groups. 
3.5 Period of the study 
Thestudy consumed 14 months; it started on April 2016 after the acceptance of the 
proposal, then conducting the administrative procedures and gaining ethical approval. Pilot 
study conducted in September 2016. Data collecting continue to January 2017, data 
analysis and writing final report continued to march 2017, data analysis and writing final 
report continued to May 2017. (Annex 3) describe the activities of the research and 
duration of each activity. 
 
 
 
 
3.6 Eligibility criteria 
3.6.1 Inclusion Criteria for Case 
Case participant male and female that diagnosis of osteoporosis confirmed by specialized 
physician using DEXA scan in which T score be < -2.5.The study done by matching 
gender, age and place of treatment between case and control groups. 
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3.6.2 Exclusion 
- Pregnant women. 
- Participants aged more than 70 years. 
3.6.3 Inclusion criteria for control 
A control is a participant male and female whom diagnosis confirmed by specialized 
physician after doing DEXA scan in which T score > -1. Controls were chosen from the 
previous mentioned centers and matching with case from the same center. 
3.7 Study instrument: 
After reviewing previous studies and literature,the questionnaire was arranged in a logical 
sequence to facilitate the interview and was written in both English and Arabic language 
(Annex 4,5). The question was closed- ended questions.  
The researcher used self- administered structured interview questionnaire. The 
questionnaire divided into four domains as following: 
1. Socio-demographic factors contains information about age, gender, education, 
occupation, marital status and family income. 
2. Life style factors contains BMI, nutrition habits(tea, coffee, cola, milk, dairy product), 
physical activity, smoking, calcium and vitamin D supplement, exposure to sun and 
cooking in Aluminum cookware. 
3. Medical history factor which include family history, menstrual 
history(female),personal fracture, eating disorder, rheumatoid arthritis (RA), Diabetes 
Mellitus (DM), depression, chronic constipation ,chronic diarrhea and cancer. 
4. Medication use factors contain drugs used as corticosteroid (prednisolone), 
contraceptive, breast cancer therapy,anticonvulsion, prostate cancer therapy, Lasix, 
proton pump inhibitors PPI, antidiabetic and antihypertension drug. 
 
3.8 Data collection 
Data was collected through direct and indirect methods. Direct methods include 
anthropometricmeasurement (measurement of weight and height for both case and control 
groups). Indirect data collection carried out through structured interviews (face-to-face 
interviews questionnaire). The researcher collected the data with two expert and qualified 
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assistants. The assistants trained well on how to interview the clients in the same way as 
the researcher.   
3.9 Data entry and analysis 
The collected data introduced to the computer using SPSS (Statistical Package for Social 
Science version 20). 
Statistical methods carried out as follow: 
 Reviewing the records and filling out the questionnaire. 
 Developing an appropriate data entry model. 
 Coding the participant data. 
 Defining and recording the variables. 
 Cleaning the data. 
 Descriptive statistics frequencies, percentage, means and standard deviation(SD) 
analysis were used in the study. 
 Bivariate analysis was used via Odds Ratio to show if there are statistical 
significant association between factors and osteoporosis. 
 Multivariate analysis was used by binary logistic regression to determine which 
pure independent variables affect the probability of an outcome of osteoporosis and 
results were presented with beta coefficient, OR with CI 95% and p value. 
3.10 Scientific Rigor 
3.10.1 Validity of Instrument 
Validity of an instrument is a determination of the extent to which the instrument reflect 
the abstract being examined. 
Face and content validity: The researcher submitted the questionnaire to group of experts 
panel (Annex 6) in order to evaluate its quality and to make the needed suggestions. All 
suggestion from each expert are taken in concern by the researcher and added as extra 
question in the questionnaire. 
Reliability of instrument 
 Pilot study 
Small-scale experiment conducted before starting data collection in order to know the 
extent of ambiguity in the instrument. Additionally, piloting allows the data collectors to 
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gain experience dealing with data collection instrument. Piloting performed on 20 client, 
10 cases and 10 control, where obtained from the selected center that allow for further 
improvement of validity and reliability of the instrument. After that, the piloting cases and 
controls were added to the sample.  
3.11 Ethical Consideration 
The researchercommitted to all ethical considerations required to conduct a research, 
which includes: 
 An official letter of approval to conduct the study obtained from theHelsinki 
committee (Annex 7) and school of public health at Al-Quds University. 
 An official letter of request obtained from the general director of Palestinian 
German Diagnostic Center (Annex 8). 
 To guarantee participant rights, a covering letter indicating that the participation is 
voluntary and the right to refuse was preserved. 
 Confidentiality was given and maintained until the end of the study. 
 Every participant in the study was provided by complete explanation about the 
research purpose and benefits of the result on community health. 
3.12 Limitation of the Study 
The main constraints faced the researcher 
 Selected the case group with osteoporosis and the diagnosis confirmed by 
DEXA took too much time. 
 Selected the controls after doing DEXA scan took too much time. 
 Matching more than two characteristics between case and control groups. 
 Limited scientific resource like books and journal. 
 Lack of local research about the study topics. 
 Limited time available to conduct the study 
4 Chapter 4 
Results and discussion 
4.1 Introduction 
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This chapter illustrates the results of statistical analysis of the data; firstly include 
descriptive analysis that presents the participant characteristics and demonstrates the 
variation between cases and controls including frequencies and percentage. In addition, it 
showed the different risk factors of socio-demographics, life style, medical and medication 
factors that related to the development of osteoporosis among adults in Gaza Strip. Chi-
square statistical test was used to show the differences between categorical variables, in 
addition,multiple logistic regression model was presented to show most important risk 
factors of osteoporosis. Finally, these results were discussed in comparison with literature 
review and related previous studies. 
4.2 Descriptive Analysis 
4.2.1 Selected socio-demographic characteristics of the study population 
The study sample consisted of 160 participants, divided into two groups; case group 
consisted of (80) male and female participants who had osteoporosis and control group 
consisted of (80) male and female participants without osteoporosis.  
Table (‎4.1):Frequencies of study population according to gender, age and place of 
treatment 
Variable 
Case Control 
N % N % 
Gender 
Female 65 81.2% 65 81.2% 
Male 15 18.8% 15 18.8% 
Total 80 100 80 100 
Age 
20-30years 11 13.8% 11 13.8% 
31-40 years 18 22.5% 18 22.5% 
41-50 years 18 22.5% 18 22.5% 
51-60 years 20 25% 20 25% 
More than 60 13 16.2% 13 16.2% 
Total 80 100 80 100 
Place of 
treatment 
Palestinian German 
Diagnostic Center 
80 100% 80 100% 
Total 80 100 80 100 
 
Table (4.1) showed that the study population consisted of 65 (81.2%) females and 15 
(18.8%) males had osteoporosis among the case group were 65 (81.2%) female and 15 
(18.8%) male without osteoporosis among the control group. Age was divided into five 
groups each group was matched between case and control group, 11(13.8%) cases and 
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11(13.8%) controls their age between 20- 30 years. In addition, 18 (22.5%) cases and 18 
(22.5%) controls their age between 31-40 years; the same number and percentage age from 
41-50 years. While the highest number were between 51- 60 years 20 (25%) cases and 20 
(25%) controls. Finally,13(16.2%) cases and 13 (16.2%) controls were aged more than 60 
years. The researcher noted that more than two third of our sample were over age of 40 
years, this result was expected because mainly osteoporosis affected people over this age 
group. 
Concerning place of treatment 80 (100%) cases and 80(100%) controls were taken 
fromPalestinian German Diagnostic Center in which their diagnosis confirmed by DEXA 
scan technique that they are osteoporotic (case) or osteoporosis free (control). The equality 
in the number of cases and controls groups in gender, age and place of treatment were due 
to matching. 
 
Figure (‎4.1):Percentage distribution of study population according to participant 
occupation. 
Figure (4.1) showed that 27 (33.8%) casesand 32 (40%) controls were employed while 53 
(66.3%)cases and 48 (60%) controls were unemployed.This result was expected, only 
about one third of our sample were employed due to sanction, low economic status and 
siege.This result is consistent with the report of World Bank, (2017)which mentioned that 
Palestinian poverty rate remains at about one quarter of its population. Unemployment has 
gone up from 25% in 2015 to 27% in 2016, though it varies from a high 42% in Gaza to 
18% in the West Bank. 
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Table (‎4.2):Percentage distribution of study population according to education level 
Variable 
Case Control 
N % N % 
Education 
level 
Illiterate 5 6.3% 2 2.5% 
primary 6 7.5% 2 2.5% 
Preparatory 6 7.5% 7 8.8% 
Secondary 30 37.5% 26 32.5% 
Diploma 7 8.8% 10 12.5% 
University 25 31.1% 28 35% 
More 1 1.3% 5 6.2% 
Total 80 100 80 100 
 
According to the table (4.2),five(6.3%) from cases and two(2.5%)from controls were 
illiterate, 6(7.5%) cases and 2(2.5%) controls were primary education, 6(7.5%) cases and 
7(8.8%)controls were preparatory education. Also, 30(37.5%) from cases and 26(32.5%) 
from controls were secondary education. In addition, 7(8.8%) cases and 10(12.5%) 
controls were diploma education and 25(31.3%) of cases and 28(35%) from controls were 
have university education. Finally, one(1.3%) from cases and five (6.2%) from controls 
were have more than university degree.Our result showed that more than two third (79%) 
of our sample were educated and have at least secondary school certificate, this result 
consistent with the PCBS,(2017) report which mentioned that literacy rates are highest in 
the Gaza Strip, with a literate population of 96.8%, compared to 96% in the West Bank 
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Figure (‎4.2):Percentage distribution of study population according to living area 
 
Figure (4.2) showed tht (40%)cases and (43%) controls of the study population were from 
south area. (31.3%) of cases and (33.8%) of controls  from Gaza city. The lowest 
percentage group were from north (6.3%) of cases and (6.3%) from controls. Middle zone 
account for (22.5%) of cases and (16.3%) from controls.  
 
Figure (‎4.3):Percentage distribution of study population according to level of income 
 
Figure (4.3) showed that (31.3%) of cases and (26.3%) of controls their income less than 
1000NIS while (27.5%) cases and (35%) of controls their income were between 1000-
2000NIS. (28.8%) of cases and (27.5%) of controls their income were from 2001-3000 
NIS. The lowest percentage of study population their income were more than 4000NIS, 
(12.5%) cases and (11.3%) controls. Our result showed that two third of our participants 
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their income less than 2000NIS which consistent with UNRWA (2014) report, which 
estimate that the average monthly salary in Gaza amounted to US$ 174; with a poverty rate 
of 39 percent, an 11 percent increase since 2013. 
4.3 Inferential Statistics 
Inferential statistics usedto show the relationship between variables by using statistical 
tests. 
4.3.1 Bivariate Analysis 
4.3.1.1 Risk factors of osteoporosis 
4.3.1.1.1 Socio-Demographic Variables 
The researcher supposed that the socio- demographic variables of the participant might 
play a role as predisposing risk factors for osteoporosis. These variables include participant 
occupation, marital status, level of income and education level. 
Table (‎4.3):Socio-demographic factors and development of osteoporosis 
Variable 
Case Control Chi-
Square 
Test 
P-value 
N % N % 
Living area 
North 5 6.3% 5 6.3% 1.018 0.797 
Gaza 25 31.3% 27 33.8% 
Middle Zone 18 22.5% 13 16.3% 
South Area 32 40.0% 35 43.8% 
Total 80 100 80 100 
Level of 
income 
<1000 25 31.3 21 26.3 1.143 0.767 
1000-2000 22 27.5 28 35 
2000-4000 23 28.8 22 27.5 
>4000 10 12.4 9 11.2 
Total 80 100 80 100 
Education 
level 
Illiterate and 
primary 
11 13.8% 4 5% 
4.989 0.288 
Preparatory 6 7.5% 7 8.8% 
Secondary 30 37.5% 26 32.5% 
Diploma 7 8.8% 10 12.5% 
University 26 32.4% 33 41.2% 
total 80 100 80 100 
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Table (4.3) showed that there is no statistical significant difference between living area and 
having osteoporosis (chi square 1.018, P value 0.797). Also level of income showed that no 
statistical significant difference with having osteoporosis (chi square = 1.143 with P value 
= 0.767). Our result is inconsistent with study done by Navarro et al (2009) in Spain 
concluded that poverty has been shown to be a definite risk factor for osteoporosis. While 
there were a debate in the literature on the relation between level of income and 
osteoporosis, a study evaluating Canadian women has shown that lower income was found 
to correlate with a greater likelihood of qualifying for osteoporosis treatment, based on an 
assessment of the probability of hip fracture (Brennan et al., 2014). 
In addition, the result showed that there is no statistical significant difference between 
education level (x
2
 = 4.989, P value = 0.288) and having osteoporosis. This result is 
inconsistent with study of Maddah et al. (2011) which conclude that those post-
menopausal women with low education were more likely to have osteoporosis than high-
educated women and it was approximately five times more than high educated women. 
The researcher estimate that most of the people who are living in Gaza strip were educated 
and have enough knowledge about a well balance diet. 
Table (‎4.4):Maternal factors and development of osteoporosis among case and control 
groups 
Variable 
Case Control Chi 
square 
P 
value N % N % 
Marital 
status 
Single 2 2.5% 9 11.3% 5.272 0.153 
Married 66 82.5% 62 77.5% 
Widow 8 10% 5 6.3% 
Divorced 4 5% 4 5% 
Total 80 100 80 100 
Having 
children 
Yes 73 93.6% 65 90.3% 0.558 0.455 
No 5 6.4% 7 9.7% 
Total 78 100 72 100 
Number of 
children 
4 and less 30 41.9% 32 48.4% 0.745 0.388 
5 and more 43 58.1% 33 51.6% 
Total 73 100 65 100 
History of 
abortion 
Yes 39 60% 29 44.6% 3.083 0.079 
No 26 40% 36 55.4% 
Total 65 100 65 100 
Mother 
feeding 
Breast 58 93.5% 41 78.8% 5.35 0.021* 
Bottle 4 6.5% 11 21.2% 
Total 62 100 52 100 
Breast 
feeding 
duration 
1 year and less 32 54.2% 22 53.7% 0.003 0.954 
More than 1year 26 45.8% 19 46.3% 
Total 58 100 41 100 
*the relationship is significant at 0.05 level 
** Fisher-Exact test is used for 2*2 tables 
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Table (4.4) showed that there was no statistical significance differences between marital 
status and osteoporosis (chi square 5.272, P value = 0.153). These finding was inconsistent 
with the result of Brennan et al. (2009)which showed that there is a strong association 
between increase risks of fracture inunmarried, single, divorced, or widowed population 
compared to married couple.In addition, the table showed that there was nostatistical 
difference between either having children or number of children and osteoporosis(chi 
square = 0.558, p value = 0.455; chi square = 0.745, p value= 0.388) respectively.Our 
results were consistent with kaur et al. (2003) which revealed that bone density remains 
stable during pregnancy and not affecting Body Mass Index (BMD). Also, pregnancy and 
lactation associated osteoporosis is often confused with other causes of low back pain 
during pregnancy. 
For participants having a history of abortion, 39 (60%) from the case group while 29 
(44.6%) from the control group.  The Pearson Chi-squared value of 3.083 with p-value 
0.079 indicates no statistical differencebetween having a history of abortion and the status 
of having osteoporosis.This result indicates that the proportion difference between the case 
and control groups is insignificant at 0.05 level. Our result is inconsistent with, Ozdemir et 
al.(2005) study, which illustrate that women who had five or more abortions were found to 
have significantly lower spine BMD values compared to women who had no abortions or 
women who had one or two abortions. Our findings indicate that the increased risk of 
osteoporosis is not associated with the increased number of pregnancies and abortions. 
Concerning breast-feeding, 58 (93.5%) of the case group and 41(78.8%) of the control 
groupused breast-feeding while 4 (6.5%) from case group and 11(21.2%) from control 
groupused bottle-feeding. The Pearson Chi-squared value of 5.35 with p-value 0.021 
indicates statistical differencesbetween using breast-feeding and the having osteoporosis. 
This result indicates that the proportion difference between the case and control groups is 
significant at 0.05 level. Our study results were congruent with Karlsson et al. (2005) study 
which concluded that lactation has more consistent and profound effects on bone density 
that bone loss of 3 to 10 percent at the spine and hip are seen over three to six months of 
lactation. Moreover, Bone loss is related to duration of lactation and duration of 
amenorrhea and is not prevented by calcium supplementation. 
In contrast, the table showed there is no significant difference between breast-feeding 
duration and having osteoporosis (x
2
 = 0.003, P value = 0.954). 
4.3.1.1.2 Life StyleVariables 
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The researcher supposed that the life style factors might play role as predisposing factors 
for osteoporosis. These variables include BMI, smoking, exercise activity, sunexposure, 
cooking in aluminum cookware, drinking (tea, coffee,soft drinks and milk) and taking 
calcium and vitamin D supplement. 
Table (‎4.5):Life style factors and developing of osteoporosis among case and control 
groups. 
Variable 
Case Control Chi  
square 
P value 
N % N % 
BMI 
<29.9 51 63.8% 48 60% 0.238 0.625 
>29.9 29 36.2% 32 40% 
Total 80 100 80 100 
Exercise 
activity 
Don’t do 52 65% 41 51.3% 3.682 0.298 
Daily 19 23.8% 24 30% 
Weekly 9 11.3% 15 18.8% 
Total 80 100 80 100 
Sun 
exposure 
Yes 56 70% 55 68.8% 0.029 1.000 
No 24 30% 25 31.3% 
Total 80 100 80 100 
Cooking in 
Aluminum 
cookware 
Yes 53 66.3% 43 53.8% 2.604 0.146 
No 27 33.7% 37 46.2% 
Total 80 100 80 100 
*The relationship is significant at 0.05 level 
** Fisher-Exact test is used for 2*2 tables 
In regarding to Body Mass Index (BMI), table (4.5) showed that the chi -square value of 
0.238 with P value 0.625 indicate nostatisticaldifference between BMI and having 
osteoporosis. This result indicates that the proportion difference between the case and 
control groups is insignificant at 0.05 level. 
In addition,in  exercise activity more than half of our study case (65%) and (51.3%) control 
groups are not doing any type of exercise. the Pearson chi square value 3.682 with P value 
0.298 indicate nostatistical differencebetween exercise activity and having osteoporosis. 
the proportion difference between case and control groups wereinsignificant at 0.05 level. 
Our result is inconsistent withHeyward & Gibson (2014) who revealed thatpeople who 
spend a lot of time sitting have a higher risk of osteoporosis than do those who arewalking, 
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running, jumping, dancing and weightlifting.For participants who are expose to sun light, 
the Pearson chi square and P value are (0.029 and 1.00) respectively which indicate 
nodifference between sun exposure and having osteoporosis.The researcher attributes 
absence of significant due to the abundant of sunshine all time of the year in Gaza strip and 
to the smaller size of study sample. 
In addition, the table showed that there was nostatistical significant difference between 
cooking in Aluminum cookware and having osteoporosis (x
2
 = 2.604, P value = 0.146). 
This result is inconsistent withBassioni,et al.(2012) study that showed that cooking with 
aluminum increases the risk of developing Osteoporosis and alzehaimers disease. 
Table (‎4.6):Drinking coffee, tea and soft drinks and development of osteoporosis among 
case and control groups 
Variable 
case Control Chi 
square 
P value 
N % N % 
Drinking 
coffee 
Not drink 36 45% 38 47.5% 3.299 0.192 
1-3 
cups/day 
32 40% 37 46.3% 
4 and 
more/day 
12 15% 5 6.3% 
Total 80 100 80 100 
Drinking 
Tea 
Non 17 21.3% 13 16.3% 1.129 0.569 
1-5 
cups/day 
55 68.8% 61 76.3% 
6 and 
more/day 
8 10% 6 7.5% 
Total 80 100 80 100 
Soft 
drink(cola) 
Non 55 68.8% 58 72.5% 0.271 0.603 
1 or more  
cups/week 
25 31.2% 22 27.5% 
Total 80 100 80 100 
*The relationship is significant at 0.05 level 
** Fisher-Exact test is used for 2*2 tables 
Table (4.6) showed that 36(45%) of cases were not drink coffee, 32(40%) drink 1-3 cups 
daily and 12(15%) drink more than 4 cups daily.While 38 (47.5%) of control groups were 
not drink coffee, 37 (46.3%) drink 1-3 cups daily and 5 (6.3%) drink more than 4 cups 
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daily.Our result showed that drinking coffee had notsignificant association with 
osteoporosis (x2 = 3.299, p value = 0.192). National Osteoporosis Foundation (NOF), 
(2002) recommended that drinking more than three cups of coffee every day may interfere 
with calcium absorption and cause bone loss. Our results inconsistent with a study carried 
out by Hallstorm et al. (2006) indicate that a daily intake of 330 mg of caffeine, equivalent 
to 4 cups (600 ml) of coffee, or more may be associated with a modestly increased risk of 
osteoporotic fractures, especially in women with a low intake of calcium. 
Furthermore, the study showed that showed that 17(21.3%) of cases and 13(16.3%) from 
controls not drink tea while 55(68.8%) cases and 61(76.3%)from controls drinking 1-5 
cups per day. Also, 8(10%) of cases and 6 (7.5%) from controls drink more than 5 cups per 
day. This result indicates that nodifference between drinking tea and having osteoporosis 
(x
2
 =1.129, P value = 0.569). 
On the other hand, drinking soft drink as cola illustrate that 55(68.8%) of cases 58 (72.5%) 
of controls not drink cola at all while 25(31.2%) of cases and 22 (27.5%) from control 
group drink one or more cups per week. This result showed that (x
2
 = 0.271, p value = 
0.603) which indicateno statistical difference between drinking soft drinks and 
osteoporosis. This result indicate that the proportion difference between case and control 
groups isinsignificant at 0.05 level. 
4.3.1.1.3 MedicalCondition Variables  
The researcher suppose that number of medical factors might be predisposing factors for 
osteoporosis. These factors include family history of having osteoporosis, menstrual 
history for female, personal hip and vertebral fracture, Rheumatoid Arthritis RA, eating 
disorder, hyperthyroidism and cancer disease. 
 
 
 
 
 
 
 
 
 
Table (‎4.7):Family history of medical condition and development of osteoporosis 
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Variable 
Case Control Chi 
square 
P value 
N % N % 
Family 
history of 
osteoporosis 
Yes 31 38.8% 12 15% 11.481 0.001* 
No 49 61.3% 68 85% 
total 80 100 80 100 
Family 
history of 
hip fracture 
Yes 15 18.8% 4 5% 7.227 0.013* 
No 65 81.3% 76 95% 
total 80 100 80 100 
Family 
history of 
vertebral 
fracture 
Yes 3 3.8% 2 2.5% 0.206 0.500 
No 77 96.3% 78 97.5% 
total 80 100 80 100 
Family 
history of 
Curve in the 
spine 
Yes 8 10.0% 9 11.3% 0.066 0.798 
No 72 90% 71 88.8% 
total 80 100 80 100 
The relationship is significant at 0.05 level 
Table (4.7) showed that participant with family history of osteoporosis constitutes a 
proportion of(38.8%) cases while (15%) of controls with (chi-square = 11.481 and P value 
= 0.001)which means significantstatistical difference between having family history of 
osteoporosis anddevelopment of osteoporosis. This result indicates that the proportion 
difference between case and control groups is significant at 0.05 level. 
In addition participant with family history of hip fracture contribute to 15 (18.8%) from 
case group while 4 (5%) of control group (x
2
= 7.227, p value = 0.013) means that there is 
significant association between family history of hip fracture and osteoporosis. 
In contrast, family history of vertebral fracture 3 (3.8%) of cases and 2 (2.5%) of control 
with (x
2 
= 0.206 and p value = 0.5) indicate that there is no significant difference between 
family history of vertebral fracture and osteoporosis. 
Furthermore, there is no significant difference between family history of curve in the spine 
and osteoporosis (x
2
 = 0.066 and p value = 0.798).Our study results is consistent with 
Soroko et al.(1994) study, which concluded that men and women with a family history of 
osteoporosis had lower BMD than those with a negative family history. In men, a positive 
family history was associated with lower BMD at the hip (P= 0.01), whereas in women a 
significant association was observed for the spine (P = 0.02). 
 
 
Table (‎4.8):Personal history of hip and vertebral fracture, rheumatoid arthritis (RA), eating 
disorder, hyperthyroidism and cancer with development of osteoporosis 
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Variable 
case Control Chi 
square 
P value 
N % N % 
Personal vertebral 
fracture 
Yes 6 7.5% 0 0% 6.234 0.014* 
No 74 92.5% 80 100% 
total 80 100 80 100 
Personal hip 
fracture 
Yes 9 11.2% 2 2.5% 4.783 0.029* 
No 71 88.8% 78 97.5% 
total 80 100 80 100 
Rheumatoid 
Arthritis (RA) 
Yes 23 28.8% 9 11.2% 7.656 0.009* 
No 57 71.2% 71 88.8% 
Total 80 100 80 100 
Eating disorder 
Yes 5 6.2% 1 1.2% 2.771 0.210 
No 75 93.8% 79 98.8% 
total 80 100 80 100 
Hyperthyroidism 
Yes 5 6.2% 0 0% 5.161 0.029*- 
No 75 93.8% 80 100% 
total 80 100 80 100 
Cancer 
Yes 9 11.2% 5 6.2% 1.252 0.402 
No 71 88.8% 75 93.8% 
total 80 100 80 100 
*The relation is significant at 0.05 
** Fisher-Exact test is used for 2*2 tables 
 
Table (4.8) showed that there is a significant relationship between personal vertebral 
fracture and hip fracture with having osteoporosis (x
2
 = 6.234, p value = 0.014);(x2 = 
4.783, p value = 0.029) respectively. The result indicates that the proportion difference 
between case and control groups is significant at 0.05 level. These results were agreed 
with Kanis et al, (2004) study that explore in meta-analysis of 11 prospective cohort 
studies of fracture risk in men or women with prior fracture. They reported increased risks 
of any fracture (relative risk [RR] 1.8, 95% CI 1.6-1.9), osteoporotic fracture (RR 1.8, 95% 
CI 1.6-1.9), and hip fracture (RR 1.6, 95% CI 1.3-2.0) in both men and women, even after 
adjustment for BMD. 
In addition, the table showed that participant with Rheumatoid Arthritis (RA) constitutes of 
23 (28.8%) of cases and 9 (11.2%) of control with (x
2
 = 7.656, P value = 0.009). This 
result means there is a significant relationship between RA and osteoporosis. This result is 
congruent with Kanis et al. (2008) study, which recognized that patients with RA have a 30 
62 
 
percent increased risk of major osteoporotic fracture and 40 percent increased risk of hip 
fracture. 
In contrast, there is no significantdifference between eating disorder (x
2 
= 2.771, p value = 
0.210) and osteoporosis. The researcher attributed that to few number of cases 5(6.2%) and 
1(1.2%) from control group that had eating disorder. 
Concerning hyperthyroidism, there is a significantdifference between hyperthyroidism and 
osteoporosis as evidence by the (Pearson chi-square value was 5.161 with P value 0.029). 
This result is consistent with Aspray et al.(2014) study,which mentioned that 
hyperthyroidism could be associated with muscle weakness and loss of lean body mass, 
which can be quite severe in some cases. This can then lead to an increased risk of falling 
and subsequent broken bone. 
Also participant with cancer disease showed that there is no significant differencewith 
osteoporosis (x
2
 = 1.252, P value = 0.402). This result is inconsistent with Reuss-Borst et 
al., 2012which assumed that cancer is a major risk for both generalized and local bone loss, 
with bone loss as assessed by bone mineral density (BMD) testing substantially higher in 
cancer patients than in the general population, independent of cancer type (Reuss-Borst et 
al., 2012). The researcher attributed that to few numbers of cases with cancer in our 
research sample. 
Table (‎4.9):Menstrual history for female medical condition and development of 
osteoporosis 
Variable 
Case control Chi 
square 
P value 
N % N % 
Menopause 
before age 
45 
Yes 12 18.5 14 21.5 0.192 0.827 
No 53 81.5 51 78.5   
total 65 100 65 100   
Removal of 
ovary 
Yes 9 13.8 0 0 9.669 0.001* 
No 56 86.2 65 100   
total 65 100 65 100   
Irregular 
period 
Yes 10 15.4 12 18.5 0.219 0.816 
No 55 84.6 53 81.5   
total 65 100 65 100   
*The relation is significant at 0.05 
** Fisher-Exact test is used for 2*2 tables 
 
Table (4.9) showed that there isinsignificant difference between early menopause and 
osteoporosis (x
2
 = 0.192, P value = 0.827). Our result is inconsistent with Sadat-Ali et al. 
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(2004) study which illustrate that  menopause is a major risk factor for osteoporosis where 
the incidence of fractures increases by about 40% with menopause in developing countries. 
 While removal of ovary showed significantdifference with osteoporosis (x
2
= 9.669, P 
value = 0.001). This result was agreed with the study of Johns Hopkins oncologist and 
epidemiologist, (2011) which explore that having both ovaries removed before age 45 is 
strongly associated with low-bone mineral density and arthritis in later years. 
Regarding to female suffer from irregular period 15.4% from cases and 18.5% from 
control group. The chi square value of 0.219 with P value 0.816 
indicateinsignificantdifference between disturbance of period and osteoporosis. The 
researcher estimate our research results due to high percentage 53(81.5%) of female in our 
study hadnot menopauseyet as opposed to 12(18.5%) who had menopause. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.1.1.4 Medication Use Variables 
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The researcher supposed that using certain type of drug might play a role as predisposing 
risk factors for osteoporosis. This type of osteoporosis known as secondary osteoporosis. 
These drugs are Corticosteroid, Proton pump inhibitors (PPIs), Loop diuretic (Lazix), 
Anticoagulant, Antihypertensive and Ant diabetic drug 
Table (‎4.10):Certain type of medication and development of osteoporosis 
variable 
case Control Chi 
square 
P value 
N % N % 
Corticosteroid 
(prednisolone 5mg) 
Yes 30 37.5% 18 22.5% 4.286 0.029* 
No 50 62.5% 62 77.5% 
total 80 100 80 100 
Proton pump 
inhibitors (PPIs) 
Yes 20 25% 12 15% 2.5 0.166 
No 60 75% 68 85% 
total 80 100 80 100 
Loop diuretics 
(Lasix) 
Yes 15 18.8% 3 3.8% 9.014 0.003* 
No 65 81.2% 77 96.2% 
total 80 100 80 100 
Anti-coagulant 
(heparin) 
Yes 18 22.5% 6 7.5% 7.059 0.008* 
No 62 77.5% 74 92.5% 
total 80 100 80 100 
Anti-diabetic drug 
Yes 14 17.5% 11 13.8% 0.427 0.664 
No 66 82.5% 69 86.2% 
total 80 100 80 100 
Anti-hypertensive 
drug 
Yes 32 40% 12 15% 12.539 0.001* 
No 48 60% 68 85% 
total 80 100 80 100 
 
Table (4.10) showed that participants used corticosteroid (prednisolone 5mg), 30 (37.5%) 
from the case group while 18 (22.5%) from the control group. The Pearson chi square 
value 4.286 with P value 0.029 indicate significant difference between using prednisolone 
and osteoporosis. This result indicate that the proportion difference between case and 
control group issignificant at 0.05 level. Our study result is consistent with Van Staa et 
al.(2000) retrospective cohort study in 244,235 oral glucocorticoid users database showed 
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a dose-dependent relationship between chronic glucocorticoid use and fracture risk, with 
high doses (prednisolone 7.5 mg/day or greater) having the highest risk . Low doses of 
glucocorticoids (prednisolone less than 2.5 mg/day) were also associated with increased 
fracture risk. 
While there is insignificantdifference between using proton pump inhibitors such as 
(pepticum)
R
and osteoporosis (x
2
 = 2.5, P value =0.166). There were a debate in the 
literature about the relation between using PPI and osteoporosis. 0ur study result is 
consistent with Targownik et al. (2010)study result  that failed to find an association 
between PPI use and a reduction of BMD in a Manitoba population consisting primarily of 
women aged >65 years. While our result is inconsistent with Eom et al. (2011)study on 
large meta-analysis, found that PPI but not H2-receptor antagonist use was associated with 
an increased risk of fracture. 
For participant used loop diuretic(Lasix) the table showed that 15 (18.8%) from cases and 
3 (3.8%) from control group with (x
2
= 9.014, P value = 0.003) indicate that there is 
significantdifference with developing osteoporosis. Our result is agreed with 
pharmacological action of drug (Lasix) that cause increase in the renal excretion of 
calcium, which can result in a hypocalcaemia state. Compensatory processes are thought to 
be responsible for the loss of bone. In addition, our study result is congruent with 
Rejnmark et al, (2006) study that Study concluded that  ever use of LD was associated with 
a crude 51% (OR 1.51; 95% CI 1.48–1.55) increased risk of any fracture and a 72% (OR 
1.72; 95% CI 1.64–1.81) increased risk of hip fracture.While use of furosemide was 
associated with higher risk estimates than use of bumetanide. 
Furthermore patient used anticoagulant heparin form a proportion of(22.5%)from cases 
and (7.5%) from controls with (x
2
= 7.059, P value = 0.008) also indicate a 
significantdifference with osteoporosis. This result agreed withRajgopal et al. (2008) study 
which mentioned that long-term unfractionated heparin (UH) use is associated with an 
increased risk of osteoporosis, up to one-third of patients on long-term UH therapy have a 
subclinical reduction of BMD. 
Regarding participant whom taken diabetes mellitus drug, (17.5%) from cases and (13.8%) 
from controls. The Pearson chi square value is 0.427 and P value 0.664 means there is 
insignificantdifference between taken DM drugs and osteoporosis.  
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In contrast, participant used hypertension drugs account for (40%) from the cases group 
and (15%) from the controls group with (x
2
 = 12.539, P value = 0.001). This result 
indicatesignificantdifference between taken hypertensive drug and osteoporosis. There 
were a debate in the literature about the effect of hypertension drug on osteoporosis as the 
two disease are often coexisting among the aging population.However, our result is 
consistent with Ilić etal. (2013) study mentioned that treatment ofhypertension affects bone 
mineral density and, therefore, can worsen osteoporosis. 
4.4 Logistic Regression Analysis 
Logistic regression is the appropriate regression analysis to conduct when the dependent 
variable is dichotomous (binary).  It was employed to predict the probability that 
participants to have osteoporosis.  Logistic regression used to describe data and to explain 
the relationship between one dependent binary variable and one, more nominal, ordinal, 
interval, or ratio-level independent variables. 
Table (‎4.11):logistic regression for socio-demographic risk factors and osteoporosis 
Variable 
 
P value 
Adjusted 
odds 
ratio 
95% C.I.for 
EXP(B) 
Lower Upper 
Marital status 
Single 
 
0.160 9.577 0.411 223.399 
Married 0.999 2.94E+09 0.000  
Divorce and widow ®     
Abortion 
history 
> 4 times 0.646 1.674 0.185 15.118 
3times 0.861 0.814 0.081 8.196 
2 times 0.800 0.745 0.077 7.228 
One time ®     
Feeding method 
Breast 0.079 8.790 0.780 99.035 
Bottle ®     
Occupation 
Employed 0.292 2.913 0.398 21.308 
Unemployed ® 0.292 2.913 0.398 21.308 
Level of 
income 
< 1000 NIS 0.917 0.865 0.057 13.082 
1000- 2000 NIS 0.549 0.486 0.046 5.158 
2001-4000 NIS 0.382 2.801 0.279 28.150 
>4000 ®     
Table (4.11) represent the logistic regression for socio-demographic risk factor after 
adjusting age, gender and place of treatment conclude that,there is no significant risk 
factors between socio-demographic factors such as marital status, abortion history, feeding 
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method, occupation and level of income and development of osteoporosis as evidence by P 
value more than 0.05.The result of the study is consistent with Brennan et al. (2009)study 
which concluded that conflicting evidence exists regarding the relationship between 
osteoporotic fractures and levels of income and education.In addition,Smith et al. (1995) 
mention that Pregnancy- and lactation-associated osteoporosis is a rare condition affecting 
pregnant or breastfeeding women. 
 While our study results were inconsistent with Ozdemir et al.(2005) mention that women 
who had five or more abortions were found to have significantly lower spine BMD values 
compared to women who had no abortions or women who had one or two abortions. In 
addition, inconsistent result showed withKarlsson et al. (2005) study that revealed that  
lactation has more consistent and profound effects on bone density that bone loss of 3 to 10 
percent at the spine and hip are seen over three to six months of lactation.The differences 
with our study results might be due to spread of maternity health centers among all cities in 
Gaza strip that delivered primary health care for pregnant and lactating women also the 
increased number of  educated people in Gaza strip lead to increase knowledge about 
healthy nutrition. 
Table (‎4.12):logistic regression for life style risk factors and osteoporosis 
Variables P value 
Adjusted 
odds 
ratio 
95% C.I. for 
EXP(B) 
Lower Upper 
BMI 
>29.9 0.066 0.937 0.874 1.004 
<29.9 ®     
Drinking tea 
Yes 0.424 1.081 0.893 1.307 
No®     
Drinking coffee 
Yes 0.161 1.189 0.933 1.515 
No®     
How much milk 
do you drink? 
1 cup per month 0.202 2.172 0.661 7.140 
1 cup per week 0.584 1.448 0.386 5.435 
Non 0.027* 5.775 1.215 27.458 
1 cup per day ®     
Exercise activity 
Non 0.284 4.124 0.308 55.222 
Weekly 0.547 2.278 0.157 33.139 
Monthly 0.846 1.318 0.081 21.483 
Daily®     
Sun exposure 
Yes 0.822 1.107 0.455 2.692 
No®     
Using Aluminum 
cookware for 
cooking 
Yes 0.061 2.181 0.964 4.933 
No®     
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Table (4.12) showed that there is significant risk factors between not drinking of milk and 
development of osteoporosis (OR 5.775, 95%C.I. 1.215-27.458, P value 0.027). This study 
results is consistent with Matthews et al. (2011) which showed that women whose dairy 
intake was once a day or more had a 62% reduction in the likelihood of having 
osteoporosis (OR 0.38, 95%C.I. 0.17–0.86) (Pvalue0.02) compared to women whose dairy 
intake was less than twice a week. 
This study is inconsistent witha 2005 review published in Pediatrics showed that milk 
consumption does not improve bone integrity in children (Lanou et al., 2005). Similarly, 
the Harvard Nurses’ Health Study, which followed more than 72,000 women for 18 years, 
showed no protective effect of increased milk consumption on fracture risk(Feskanichet 
al., 2003). 
Whereas, BMI, drinking tea and coffee, exercise activity, using aluminum cookware and 
sun exposure were not associated with osteoporosis in our study. 
Study showed that any weight-bearing exercise and activities that promote balance and 
good posture are beneficial for bones. Furthermore, walking, running, jumping, dancing 
and weightlifting seem particularly helpful (Heyward & Gibson., 2014). However, our 
study result observed that exercise activity had no association with development of 
osteoporosis. 
Coffee, tea and soft drinks (sodas) contain caffeine, which may decrease calcium 
absorption and contribute to bone lossthatinterfere with calcium absorption and cause bone 
loss. A study showed that a daily intake of 330 mg of caffeine, equivalent to 4 cups (600 
ml) of coffee, or more may be associated with a modestly increased risk of osteoporotic 
fractures(Hallström et al., 2006) and National Osteoporosis Foundation recommend that  
Colas may have other chemicals, besides phosphoric acid and caffeine that can affect the 
bones. People with osteoporosis should not drink more than five cola drinks a week (NOF, 
2002).This study however revealed no significant difference between coffee, tea and soft 
drink intake and osteoporosis. 
Aluminum cookware is cheap and widely available and it has a negative consequence for 
health. A study published in the International Journal of Electrochemical Science has 
discovered that cooking with aluminum increases the risk of developing Osteoporosis and 
alzehaimers disease (Bassioni, et al., 2012). Our study revealed that no significant 
difference between using Aluminum cookware and develop of osteoporosis. 
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Table (‎4.13):logistic regression of family history risk factors and osteoporosis 
Variables P value 
Adjusted 
odds ratio 
95% C.I.for EXP(B) 
Lower Upper 
Family history of 
osteoporosis 
yes 0.002* 3.522 1.589 7.809 
No®     
Family history of hip 
fracture 
Yes 0.019* 4.209 1.273 13.918 
No®     
Family history of 
vertebral fracture 
Yes 0.616 0.584 0.071 4.780 
No®     
Family history with 
curve in the spine 
Yes 0.580 0.731 0.240 2.222 
No®     
As shown in table (4.13), there is significant risk factors between family history of 
osteoporosis and development of osteoporosis (OR 3.522, 95%CI 1.589-7.809, p value 
0.002). This result is consistent withRobitaille et al., (2008) study which concluded that 
women with a family history of osteoporosis were2.4 times more likely to have 
osteoporosis than women without such history(Robitaille et al., 2008).  
In addition, there is significant risk factors between family history of hip fracture and 
development of osteoporosis (OR 4.209, CI 1.273-13.918, and p value 0.019).  This study 
consistent withCummings et al. (1995) study  which reveal thatin a first-degree relative 
parental, history of hip fracture is associated with a twofold increased risk of hip fracture in 
women, regardless of BMD (Cummings et al., 1995). 
In contrast, There is no significant risk factor between family history of vertebral fracture 
and family history of with curve in the spine and development of osteoporosis (OR 0.584, 
CI 0.071-4.780, p value 0.616; OR 0.731 CI 0.240-2.222, p value 0.580) respectively. 
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Table (‎4.14):logistic regression of menstrual history for female and osteoporosis 
Variables P value 
Adjusted odds 
ratio 
95% C.I.for EXP(B) 
Lower Upper 
Early menopause before 
age 45 
Yes 0.207 0.504 0.174 1.462 
No®     
Suffer from amenorrhea 
 ( no period and not 
pregnant) 
Yes 0.239 2.496 0.544 11.452 
No®     
Irregular period 
Yes 0.219 0.505 0.169 1.502 
No®     
Table (4.14) showed that there is no significant risk factors between menstrual history of 
female and development of osteoporosis as evidence by P value more than 0.005. Our 
study result is inconsistent with Sadat-Ali et al. (2004) study, which concluded that 
menopause is a major risk factor for osteoporosis where the incidence of fractures 
increases by about 40% with menopause in developing countries. The researcher attributed 
that the lowest percentage of female 12 (18.5%) in our study had menopause before the age 
of 45 years while 53(81.5%) had not menopause before age 45 years. Therefore,the few 
number of cases may affect our result. 
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Table (‎4.15):logistic regression of medication used and osteoporosis 
Variables P value 
Adjusted 
odds ratio 
95% C.I.for EXP(B) 
Lower Upper 
Corticosteroid tablets 
(prednisolone) for over three 
months 
Yes 0.090 2.063 0.894 4.761 
No®     
Breast cancer treatment 
yes 0.413 0.473 0.079 2.838 
No®     
proton pump inhibitors PPIs 
Yes 0.457 1.468 0.533 4.045 
No®     
Any type of contraceptive 
Yes 0.354 0.679 0.299 1.540 
No®     
Loop diuretics (Lasix) 
Yes 0.046* 4.636 1.027 20.929 
No®     
Anticoagulant drug 
( heparin) 
Yes 0.063 2.897 0.944 8.890 
No®     
Anti-diabetic drug 
Yes 0.295 0.522 0.154 1.762 
No®     
Anti-hypertension drug 
Yes 0.049* 2.702 1.003 7.280 
No®     
 
The table (4.15) showed that there is significant risk factor between using loop diuretics 
(lazix) and development of osteoporosis (OR = 4.636, 95% CI 1.027-20.929, P value = 
0.046). This result is consistent withRejnmark et al. (2010) study which showed that use of 
loop diuretics(LD) was associated with 51% (OR 1.51; 95% CI 1.48–1.55) increased risk 
of any fracture and a 72% (OR 1.72; 95% CI 1.64–1.81) increased risk of hip fracture. 
Moreover, using of furosemide was associated with higher risk estimates than use of 
bumetanide. 
In addition , the same table represent that there is significant risk factor between using 
Anti-hypertensive drug and development of osteoporosis with evidence of (OR= 2.702, 
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95% CI 1.003-7.280, P value = 0.049). Our result is consistent withChen et al., (2016) 
study which showed that the risk of osteoporosis after adjusting age, sex, comorbidities, 
and concurrent medications was higher among the users of angiotensin-converting enzyme 
(ACE) inhibitors (OR 1.64, 95% CI 1.01–2.66) than among nonusers. Patients who took 
calcium channel blockers (OR 0.70, 95% CI 0.49–0.99) were at a lower risk of developing 
osteoporosis than nonusers. Also, statistically significant differences (P value = 0.008) 
were observed between the beta-blocker and calcium channel blocker groups (Ağaçayak et 
al., 2014). 
Corticosteroids have several adverse effects on bone metabolism. Direct inhibition of 
osteoblast function, direct enhancement of bone resorption, inhibition of gastrointestinal 
calcium absorption, increase in urinary calcium loss, and inhibition of gonadal hormones 
mainly affect the trabecular bone. (Walsh et al., 2002; Sinigaglia et al., 2000; IP et al., 
1994).In our study, corticosteroid intake did not show a significant association, this could 
be because of the problem of reporting the exact type of medication 
While our study found no association between Breast cancer treatment, proton pump 
inhibitors PPIs, any type of contraceptive,Anticoagulant drug (heparin) and Anti-diabetic 
drug and development of osteoporosis. 
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Table (‎4.16):The final model of logistic regression for all variables 
Variables P value. 
Adjusted odds 
ratio 
95% C.I.for 
EXP(B) 
Lower Upper 
Feeding method  
 
Breast 0.008* 8.742 1.774 43.066 
Bottle®     
BMI 
>29.9 0.002* 0.838 0.750 0.936 
<29.9®     
How much milk do 
you drink? 
1 cup monthly 0.927 0.942 0.258 3.430 
1 cup weekly 0.337 1.882 0.517 6.849 
None 0.014* 11.225 1.639 76.898 
1 cup daily ® 
    
 using  aluminum pots 
for cooking 
Yes 0.361 1.590 0.588 4.300 
No ®     
Family history with 
osteoporosis 
Yes 0.010* 5.424 1.497 19.651 
No ®     
Family history of  a hip 
fracture 
Yes 0.087 4.717 0.799 27.841 
No ®     
Rheumatoid arthritis 
Yes 0.179 2.613 0.645 10.592 
No ®     
Corticosteroid tablets 
(prednisolone) for over 
three months 
Yes 0.518 1.491 0.444 4.999 
No ®     
Loop diuretics 
(Lasix) 
Yes 0.046* 6.621 1.030 42.551 
No ®     
Anticoagulant drug  
( heparin) 
Yes 0.104 3.061 0.793 11.811 
No ®     
Anti-hypertension 
drug 
Yes 0.029* 4.168 1.157 15.013 
No ®     
The variable is significant at 0.05 level 
Table (4.16) showed the logistic regression for all risk factors in our study it represents that 
there is significant risk factors between breast feeding and developing of osteoporosis (OR 
8.742, 95%CI 1.774-43.066, P value = 0.008). This result is consistent with Karlsson et 
al. (2005) study that revealed that  lactation has more consistent and profound effects on 
bone density that bone loss of 3 to 10 percent at the spine and hip are seen over three to six 
months of lactation. 
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Concerning Body Mass Index (BMI) represent significant protective factor with 
osteoporosis (OR 0.838, 95% CI 0.750- 0.936, P value =0.002) whileodds ratio less than 
one means participant with high BMI (obese and over obesity) protected from developing 
osteoporosis in contrast to participant with low BMI<29.9. Our study result is consistent 
with Green et al. (2004) study, which showed, that low body weight (less than 58 kg) is 
associated with increased risk of osteoporosis and fractures, possibly related to small bone 
size.  
 
 In addition, there issignificant risk factors between drinking one cup of milk monthly and 
development of osteoporosis(OR 11.225, 95%CI 1.639-76.898, P value = 0.014). This 
indicates that drinking at least one cup of milk daily or weekly protected body from 
osteoporosis. Our study result is congruent with Matthews et al. (2011) which showed that 
women whose dairy intake was once a day or more had a 62% reduction in the likelihood 
of having osteoporosis (OR=0.38, 95%CI: 0.17–0.86) (p value =0.02) compared to women 
whose dairy intake was less than twice a week. 
 
While our study result is inconsistent withLanou et al., 2005 who showed that milk 
consumption does not improve bone integrity in children. Similarly, the Harvard Nurses’ 
Health Study, which followed more than 72,000 women for 18 years, showed no protective 
effect of increased milk consumption on fracture risk(Feskanichet al., 2003). 
 
Furthermore, the table showed that participants with family history of osteoporosis is at a 
significant risk factor with developing osteoporosis (OR 5.424, 95%CI 1.497-19.651, P 
value = 0.010).This result is consistent withRobitaille et al. (2008) study concluded that 
women with a family history of osteoporosis were  2.4 times more likely to have 
osteoporosis than women without such history. 
 
Moreover, there is a significant risk factor between using loop diuretics (Lazix) and 
developing of osteoporosis(OR 6.621, 95%CI 1.030- 42.551, P value = 0.046). our study 
result is congruent with Rejnmark et al. (2010) study which showed that  use of loop 
diuretics(LD) was associated with 51% (OR 1.51; 95% CI 1.48–1.55) increased risk of any 
fracture and a 72% (OR 1.72; 95% CI 1.64–1.81) increased risk of hip fracture. Moreover, 
using of furosemide (Lazix) was associated with higher risk estimates than use of 
bumetanide. 
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Finally, the same table showed that there is significant risk factor between using Anti-
hypertensive drugs and developing of osteoporosis (OR 4.168, 95% CI 1.157-15.013, P 
value = 0.029). This result is consistent with Chen et al., (2016) study which showed that 
the risk of osteoporosis after adjusting age, sex, comorbidities, and concurrent medications 
was higher among the users of angiotensin-converting enzyme (ACE) inhibitors (OR 1.64, 
95% CI 1.01–2.66) than among nonusers. Patients who took calcium channel blockers (OR 
0.70, 95% CI 0.49–0.99) were at a lower risk of developing osteoporosis than nonusers. 
Also, statistically significant differences (P value = 0.008) were observed between the 
beta-blocker and calcium channel blocker groups (Ağaçayak et al., 2014). 
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5 Chapter Five 
Conclusion and Recommendations 
5.1 Conclusion 
This study aimed to identify the main risk factors, which are associated to osteoporosis 
among male and female in Gaza Governorates. A case-control study was undertaken to 
patient attending to Palestinian German Diagnostic Center. The target population consisted 
of two groups, the first group were cases (all participants whom diagnosed confirmed by 
doing DEXA scan T score <-2.5 during the study period and having osteoporosis 
confirmed by doctor), the second group were controls who include (all participants whom 
diagnosis confirmed by doing DEXA scan that they were osteoporosis free T score >-1 
confirmed by doctor). A convenience sample was consisted of 160 participants (80 cases 
and 80 controls) matched with gender, age and place of treatment. Validated questionnaire 
was distributed to all 160 participants during collected data time. 
The study population consisted of 160 participants, 80(50%) were cases and 80(50%) were 
controls for each group 65(81.2%) were females and 15(18.8) were males. Also 11(13.8%) 
aged 20-30years, 18 (22.5%) aged 31-40 years, 18(22.5%) aged 41-50 years, 20 (25%) 
aged 51-60 years and finally 13 (16.2%) aged more than 60 years. 
Among socio-demographic risk factors, bivariate test was used by chi-square, the result 
showed that there was a significant difference between osteoporosis and mother breast-
feeding (x
2
 = 5.35, P value = 0.021). Other factors were statistically insignificant including 
marital status, having and number of children and history of abortion. 
For life style risk factors the results of bivariate test represent that there were significant 
association with drinking soft drink (cola) were (x
2
 = 10.027, P value = 0.007) and 
development of osteoporosis. While other factors such as BMI, smoking, exercise activity, 
sun exposure, cooking in aluminum cookware, drinking coffee, tea milk and avoiding dairy 
products revealed statistical insignificant risk factors for developing osteoporosis. 
Concerning medical condition risk factors, bivariate test using chi square showed that  
there were  asignificant association between family history of osteoporosis and family 
history of hip fracture ( x
2
= 11.481, P value = 0.001), ( x
2
= 7.227, P value = 0.013) 
respectively. In addition, significant difference showed with personal vertebral fracture 
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(x
2
= 6.234, P value = 0.028), personal hip fracture (x
2
 = 4.783, P value = 0.029), 
Rheumatoid Arthritis (x
2
= 7.656, P value = 0.009), Hyperthyroidism (x
2 
= 5.161, P value = 
0.029) and removal of ovary (x
2
= 9.669, P value = 0.003). Other factors were statistically 
insignificant risk factors with osteoporosis including, family history of vertebral fracture 
and curve of spine, eating disorder, cancer, menopause before age 45(female), and 
irregular period (female). 
Regarding medication (drugs) used, bivariate test using chi square revealed that there were 
statistical difference between using corticosteroid prednisolone 5 mg, Loop diuretics 
(Lasix), Anticoagulant (heparin), anti-hypertensive drug  and development of osteoporosis 
(x
2
 = 4.286, P value = 0.029), (x
2
= 9.014, P value = 0.005), (x
2
= 7.059, P value = 0.014), 
and (x
2
= 12.539, P value= 0.001) respectively. Other factors were statistically insignificant 
including Proton Pump Inhibitors and Antidiabetic drugs. 
Multivariate analysis of risk factors for osteoporosis among adults was done using multiple 
regression to show the important and independent risk factors. Resultsshowed that there 
were significant risk factors between drinking no cup of milk and development of 
osteoporosis [(OR: 5.775, 95% CI: 1.215-27.458), P value = 0.027], family history of 
osteoporosis[(OR: 3.522, 95% C.I.: 1.589- 7.809), P value= 0.002], family history of hip 
fracture [(OR: 4.209, 95% C.I.: 1.273- 13.918), P value= 0.019] and development of 
osteoporosis. Furthermore, significant risk factor showed with using Loop diuretics (Lasix) 
[(OR: 4.636, 95% C.I.: 1.027-20.929), P value= 0.046], and Antihypertensive drug [(OR: 
2.702, 95% C.I.: 1.003- 7.28), P value= 0.049] and development of osteoporosis.   
Finally, logistic regression was done to all significant risk factors to identify the most 
significant variable in our study and the results showed that there was significant risk 
factor between breast feeding and development of osteoporosis [(OR: 1.436, 95%C.I.: 
1.436-26.842), P value = 0.015], while BMI > 29.9 showed a protective factor for 
osteoporosis[(OR: 0.871, 95%C.I.: 0.796-0.954), P value= 0.003]. 
In addition, significant risk factor was shown between family history and development of 
osteoporosis [(OR: 3.845, 95%C.I: 1.283-11.520), P value= 0.016]with no (reference 
group). 
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Furthermore, there was a significantrisk factor between using loop diuretics (Lasix) and 
development of osteoporosis [(OR: 6.967, 95%C.I.: 1.362-35.649), P value = 0.020]. at 
last, significant risk factor between using antihypertensive drug and development of 
osteoporosis [(OR: 3.004, 95%C.I.: 0.978-9.228), P value= 0.05]. 
5.2 Recommendations 
The researcher suggests the following recommendations 
1. Frequent pregnancies and lactation may predispose women in our society to lower 
BMDs. Thus, proper nutritional and family planning advices are wanted for this 
group. 
2. Optimal nutrition in the youth to achieve high peak bone mass, including adequate 
intake of calcium and vitamin D. 
3. Increase drinking of milk daily to achieve the instant amount of calcium that 
required by the body to build the bone.  
4. Assessment of every postmenopausal woman for risk of osteoporosis to determine 
the need for diagnostic tests and prevention or treatment. 
5. Early prevention of secondary causes of osteoporosis [for example, loop diuretics 
(Lasix), Antihypertensive drugs, and hyperparathyroidism]. 
6. Work with leadership of health organizations to develop and implement behavior 
change strategies within primary care, emergency departments, and orthopedic 
practices. 
7. Continue screening test to identify people at risk in order to offer treatment and 
prevent complications of disease. 
8. Health education program at primary and secondary level should be started to 
reduce the incidence of osteoporosis. 
9. Other research with increasing of sample size and using matching between one 
case and two controls. 
10. Improve awareness for different risk factors of osteoporosis among people live in 
Gaza Strip and how they can overcome these risks of osteoporosis. 
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Additional Recommendations from National Osteoporosis Foundation: 
1. Advise on a diet that includes adequate amounts of total calcium intake 
(1000 mg/day for men 50–70; 1200 mg/day for women 51 and older and men 71 
and older), incorporating dietary supplements if diet is insufficient. 
2. Advise on vitamin D intake (800–1000 IU/day), including supplements if necessary 
for individuals age 50 and older. 
3. Recommend regular weight-bearing and muscle-strengthening exercise to improve 
agility, strength, posture, and balance; maintain or improve bone strength; and 
reduce the risk of falls and fractures. 
4. Assess risk factors for falls and offer appropriate modifications (e.g., home safety 
assessment, balance training exercises, correction of vitamin D insufficiency, 
avoidance of central nervous system depressant medications, careful monitoring of 
antihypertensive medication, and visual correction when needed). 
5. Advise on cessation of tobacco smoking and avoidance of excessive soft drink 
(cola) intake. 
5.3 Suggestion for Further Studies 
- To conduct cost effectiveness studies on ongoing screening for women and men 
aged 50 years old and more to decrease the prevalence of osteoporosis. 
- Research is needed to deﬁne the mechanisms by which adaptation to a low calcium 
intake occurs, and to examine the interaction of genetic make-up, dietcomposition 
and other environmental exposures with calcium regulation and bone health. 
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Annex (2):Sample size calculation 
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Annex (3):Study Activity Timetable 
 
Activity duration 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 
Proposal writing 2 month                
Proposal 
defense and 
approval 
1 month                
Expert 
committee 
check for 
validity 
2 months                
Pilot study 1 month                
Modification                 
Data collection 4 months                
Data entry 1 month                
Data analysis 1 month                
Research 
writing 
2 months                
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Annex (4):Interviews Questionnaire (English copy) 
 
Cover letter 
Risk Factors for Osteoporosis among Adults in Gaza Governorate:  
Case – Control Study 
Our participant: 
The researcher carries out this study as a part of the requirements for master degree of 
public health at Al-Quds University, School of public health –Palestine. The study is self-
funded. 
Kindly, I would like to inform you that you have been selected to be part of my study 
research" Risk Factors for Osteoporosis among Adults in Gaza Governorate: Case – 
Control Study". You are selected because you have met the selection criteria for 
participation and your facility has been thoroughly selected as a source of data by filling a 
well and comprehensive questionnaire. 
 
The purpose of this study is to determine the main risk factors that contribute to incidence 
of osteoporosis among adults in Gaza Governorates. 
 
The researcher thankfully appreciate your effective participation in this study through 
answering the interviewer's questions that do not take more than 15 minutes. The 
researcher would like to emphasize that all data given from your side is top confidential 
and only for the purpose of scientific research. Accordingly, we will not need to mention 
names. Although t welcome your participation, participation is optional and no information 
given would be used against you whatever. 
Thanking you in advance for your cooperation 
Researcher 
ShimaShagfa 
Mobile: 0599309818 
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Questionnaire English Copy 
1-   Socio-demographic Risk Factors  
Serial NO: 1.1 Patient name: 
1.3 Age 1.2 Telephone/mobile:  
1.4 Place of treatment:  Palestinian German Diagnostic Center     
1.5 Do you have osteoporosis?                           yes                     NO 
  south area   middle zone          Gaza      North   1.6 Living Area:          
  Divorced     widow       married    single  1.7 marital status:     
1.8 If you are married, do you have children?  Yes            No 
1.9 If yes, how many? ................... 
1.10 Do you have a history of abortion?           Yes                 No 
1.11 If yes, how many times?  
1.12 Did you use breast or bottle-feeding?   
1.13 If you are breast-feeding for how long? 
1.14 Do you work?                   Yes               No 
   
1.15 If yes, what type of work? 
1.16 If you not work now, what was the previous work? 
1.17 Level of income: 
 
<1000 shekel    1000- 2000 shekel   2000- 4000 shekel >4000 shekel  
 
 
1.18 What is the highest education level you achieved? 
 
 illiterate  primary  preparatory  secondary  diploma  university 
 
 more     
 
 
2-  Life Style Risk Factors 
2.1 Height: …                2.2 Weight: …          2.3 BMI: … 
2.4 Smoking status:   non      previous    current, How many per day?  …. 
2.5 How much tea do you drink? Per collated … cups per day. 
 
2.6 How much milk do you drink?  …………cups  
 daily  weekly  monthly  non 
2.7 Do you avoid dairy products?  Yes     No 
99 
 
2.8 Exercise activity (walking, running, …)  
 don’t do daily  weekly  monthly 
2.9 Do you take calcium supplement?          Yes      No 
 
2.10 Do you take supplement of vitamin D? Yes               No 
 
2.11 What is type of your house?   flat              independent house 
 
2.12 Are your house sunny?      Yes    No  
2.13 Do you use aluminum pots for cooking?        Yes     No 
 
 
3- medical condition risk factors 
3.1 family history 
3.1 Has anyone in your family had any of the following? 
a- Been diagnose with osteoporosis?                    Yes            No 
b- Had a hip fracture?                                            Yes           No 
c- Had a vertebral fracture?                                    Yes          No 
d- Had a noticeable "dowagers hump" or curve in the spine? 
Yes           No 
 
3.2 Menstrual history for (female) 
 3.2 Have you had  
 Yes                 No a- Early menopause before age 45 
 Yes                 No b- Hysterectomy with removal of ovary before 
age 45  
 Yes                 No c- Suffer from amenorrhea ( no period and not 
pregnant) 
 Yes                 No d- Irregular period  
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4-Medication use risk factor 
4.1 Have you taken any of the following 
 Yes                 No a- Corticosteroid tablets for over three months  
If yes, which type? ............. 
For how long? 
 Yes                 No b- Antiepileptic drug  
If yes, for how long? .............. 
 Yes                 No c- Breast cancer treatment (female) 
 
 Yes                 No d- Prostate cancer drug ( male) 
 Yes                 No e- Drug that reduce acid of stomach called 
proton pump inhibitors PPIs (ex: pepticu m) 
 Yes                 No f- Any type of contraceptive? 
If yes which type? ........ 
For how long? ……. 
 Yes                 No g- Loop diuretics (Lasix) 
3.3 Personal Medical condition risk factor 
3.3 Have you had any of the following conditions? 
 Yes                 No a- Vertebral fracture 
 Yes                 No b- Hip fracture 
 Yes                 No c- Rheumatoid arthritis 
 Yes                 No d- Eating disorder causing sever weight loss 
 Yes                 No e- A condition which affect the absorption of 
food such as Crohns or celiac disease 
 Yes                 No f- Gastric bypass or any other weight loss 
surgery 
 Yes                 No g- Long period of immobility (stroke) 
 Yes                 No h- Hyperthyroidism which level of thyroid 
hormone is abnormally high 
 Yes                 No i- Parathyroid disease which level of 
parathyroid hormone is abnormally high 
 Yes                 No j- Diabetes mellitus? 
If yes, which type? type 1    type2      
 Yes                 No k- Liver disease?         
If yes? Which type 
 Yes                 No l- Kidney disease / kidney stone 
 Yes                 No m- Chronic asthma 
 Yes                 No 
 
n- Epilepsy 
 Yes                 No o- Depression 
 Yes                 No p- Chronic constipation 
 Yes                 No q- Chronic diarrhea 
 Yes                 No r- Cancer 
If yes which type?  ………………… 
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If yes, for how long? ........ 
 Yes                 No h- Anticoagulant drug ( heparin) 
If yes for how long? ................... 
 Yes                 No i- Anti-diabetic drug 
If yes, which type? 
For how long? ................... 
 Yes                 No j- Anti-hypertension drug 
If yes, which type?        
And how long? ....................... 
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 استبيان المقابمة
 
 ة، مرحبا /تي المواطن/عزيز
  
 :أقوم بدراسة حول " أبو ديس"انا طالبة دراسات عميا بجامعة القدس 
 عوامل الخطر التي تؤدي للإصابة بهشاشة العظام لدى الكبار في محافظات قطاع غزة
 
يسعدني موافقتك عمى المشاركة بالاستبيان، وأرجو التكرم بالإجابة عمى جميع أسئمة الاستبانة، مع 
العمم ان مشاركتك في ىده الدراسة طوعية، كما ان البيانات التي سيتم جمعيا سيتم استخداميا لغرض 
 .البحث العممي فقط، يرجى الإجابة عمى الأسئمة بكل امانو وصدق ولا داعي لكتابة الاسم
 دقيقة لاستكماليا، ميما كانت المعمومات التي تعطييا سوف 51ىده الاستبانة سوف تستغرق جوالي 
 .تبقى سرية وطي الكتمان ولن يطمع عمييا أحد باستثناء الباحث
 اشكر حسن تعاونك
 شيماء شقفة: الباحثة
 8189039950: رقم المحمول
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 الاستبيان
 المعلومات الاجتماعية والديموغرافية -1
 :الرقم المتسلسل:                                                                اسم المرٌض -1.1
 :العمر - 3.1:                                                               رقم الجوال -2.1
 المركز الألمانً:     مكان تلقً العلاج -4.1
  لا نعم            :       ي مرٌض بهشاشة العظام/هل انت -5.1
   المنطقة الجنوبٌة المنطقة الوسطى    غزة   الشمال :    مكان السكن-6.1
 ة/  أرملة /   مطلق متزوج   أعزب  :   الحالة الاجتماعٌة-7.1
  لا نعم    لو كنتً متزوجة، هل لدٌكً أطفال؟    -8.1 
 كم عدد الأطفال؟9.1 
  لا نعم           هل تعرضت للإجهاض؟         - 01.1
 ..........................لو الإجابة بنعم، كم عدد مرات الإجهاض؟  -11.1
 هل كنتً تستخدمٌن الرضاعة الطبٌعٌة ام الصناعٌة؟ -21.1 
 ي الرضاعة الطبٌعٌة كم المدة التً أرضعتها؟/ادا استعملت -31.1
   لا نعم   :           ي/هل تعمل -41.1
 لو كانت الإجابة بنعم، ما طبٌعة العمل؟ -51.1
 ٌن الان ما هو عملك السابق؟/لو كنتً لا تعمل -61.1
 :مستوى دخل الاسرة -71.1
  شٌكل0004 أكثر من شٌكل   0004- 0002  شٌكل 0002- 0001  شٌكل    0001 اقل من 
 :أعلى مستوى تعلٌمً حصلت علٌه  -81.1
  أكثر من  جامعة    دبلوم   ثانوي  اعدادي ابتدائً  غٌر متعلم  
 
 عيشنمط ال 2-
 :مؤشر كتلة الجسم- 3.2:                        الوزن -2.2:                                                  الطول- 1.2
 
  سابقا  لا   نعم :        هل انت مدخن-4.2
 ..........................لو كنت مدخن، كم عدد السجائر فً الٌوم 
 
 كوب..........................كم عدد اكواب الشاي المتناولة فً الٌوم؟ -5.2
 كوب..........................كم عدد فناجٌن القهوة المتناولة فً الٌوم؟ -6.2
 كوب.......................... كم كوبا من المشروبات الغازٌة تتناولٌن فً الٌوم؟-7.2
  لا نعم         ي الحلٌب؟    /هل تشرب -8.2
  الشهر الأسبوع     الٌوم    فً..........لو كانت الاجابة بنعم ، كم كوبا  
  لا نعم    هل تتجنبٌن منتجات او مشتقات الالبان ؟     -9.2
  لا نعم    هل تمارسٌن الرٌاضة مثل المشً او الجري؟      -01.2
  شهرٌا أسبوعٌا   ٌومٌا   لو كانت الإجابة بنعم، تمارسٌن الرٌاضة  
  لا نعم    هل تتناولٌن مكملات تحتوي على الكالسٌوم؟          -11.2
 
  لا نعم     هل تتناولٌن مكملات تحتوي على فٌتامٌن د؟    -11.2
 
 401
 
  بٌت مستقل شقة      :  ما طبٌعة السكن -21.2
   لا نعم   هل ٌعتبر المنزل مشمس؟     
  لا نعم     هل تعدٌن الطعام فً اوانً مصنوعة من الالمونٌوم؟    -31.2
  
 العوامل الخطر الطبية  -3
 التاريخ العائلي -1.3  
 :هل ٌوجد أي شخص فً العائلة ٌعانً من - 1.3
  لا نعم    ٌعانً من هشاشة فً العظام                  - أ
  لا نعم    أصابه كسر فً عظمة الحوض               - ب
  لا نعم    أصابه كسر فً العمود الفقري                - ت
  لا نعم     أصابه انحناء فً العمود الفقري              - ث
 
 ( للإناث فقط(تاريخ الدورة الشهرية -2.3
 هل تعانٌن من- 2.3
  لا نعم     54انقطاع الدورة الشهرٌة قبل سن  - أ
  لا نعم     54عملٌة إزالة لمبٌض قبل سن  - ب
  لا نعم     انقطاع فً الدورة الشهرٌة لسبب غٌر الحمل - ت
  لا نعم     دورة غٌر منتظمة - ث
 
 الوضع الصحي الشخصي -3.3
 : هل تعانً من أي واحدة من الامراضالاتٌة
  لا نعم       كسر فً العمود الفقري                                                     -1
  لا نعم       كسر فً عظمة الحوض                                                    -2
  لا نعم       )الروماتٌزم(التهاب المفاصل   -3
  لا  نعم       مشاكل فً التغذٌة تؤدي الى نقص فً الوزن                             -4
  لا نعم       cailec ro snhorcحالات تمنع امتصاص الطعام مثل مرض -5
  لا نعم       عملٌة تصغٌر معدة او أي عملٌة تخفٌف وزن                            -6
  لا نعم       عدم الحركة لمدة طوٌلة بسبب الإصابة بجلطة                           -7
  لا نعم       زٌادة فً افراز الغدة الدرقٌة                                               -8
  لا نعم       زٌادة فً افاز الغدة الجار درقٌة                                           -9
  لا نعم       داء السكري                                                                 -01
 ان كانت الإجابة بنعم؛ كم كان عمرك عند الإصابة؟
  لا نعم       مرض الكبد                                                                 -11
 
  لا نعم       حصوات فً الكلٌة؟                                / أمراض فً الكلٌة  -21
  لا نعم       أزمة مزمنة                                                                 -31
  لا نعم       داء الصرع                                                                 -41
  لا نعم        اكتئاب                                                                      -51
  لا نعم       امساك مزمن                                                               -61
  لا نعم       اسهال مزمن                                                               -71
  لا نعم       أي نوع من أنواع مرض السرطان مع ذكر نوعه؟                     -81
 
  
 
 
 
 501
 
 عوامل الخطر المتعلقة باستخدام الادوية -4
 :ٌن أي من الادوٌة التالٌة/هل تتناول- 1.4
 أدوٌة كورتٌزون لأكثر من ثلاثة شهور -1
 لو كانت الإجابة بنعم، 
 ما اسم الدواء ان أمكن؟
 وماهً المدة المستخدمة؟
  لا نعم    
 أدوٌة لعلاج الصرع؟ -2
 لو كانت الإجابة بنعم، كم المدة المستخدمة؟
  لا نعم    
 )للإناث فقط(أدوٌة لعلاج سرطان الثدي؟  -3
 كم المدة المستخدمة؟
  لا نعم    
 )للذكور فقط(أدوٌة لعلاج سرطان البروستاتا؟  -4
 كم المدة المستخدمة؟
  لا نعم    
 ) mucitpepالببٌتكم(أدوٌة لعلاج حموضة المعدة مثل دواء  -5
 كم المدة المستخدمة؟
  لا نعم    
 موانع للحمل -6
 ..........................لو كانت الإجابة بنعم، ما نوعه؟
 ..........................ماهً المدة المستعملة؟
 
  لا نعم     )اللازكس(مدرات للبول مثل  -7
 )الهبارٌن(مضادات للتجلط  -8
 لو كانت الإجابة بنعم، ماهً المدة المستعملة؟
  لا نعم    
 أدوٌة لعلاج داء السكر -9
 لو كانت الإجابة بنعم، ما اسم الدواء؟
 وماهً المدة المستخدمة؟
  لا نعم    
 أدوٌة لعلاج مرض الضغط؟ -01
 لو الإجابة بنعم، ما اسم الدواء أن أمكن
 وماهً المدة المستعملة؟
  لا نعم    
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Annex (6): Experts panel 
 
1. Dr. Bassam Abu Hamad 
 
Al-Quds University 
2. Dr. Yehia Abed                                       Al-Quds University 
3. Dr. Khitam Abu Hamad Al-Quds University 
4. Dr. Ashraf El-Jedi                                    Islamic University 
5. Dr. FadelNaeem Islamic University 
6. Dr. Abdrabo Abu Hashish                       Palestinian German Diagnostic 
Center manager 
7. Dr.  Saied Abo Hammra European Hospital 
8. Dr. SaadiJaber European Hospital 
9. Mr. Ali Abu Riala 
 
Al Wafaa Hospital 
10. Dr. Areefa Al-Bahri Islamic University 
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Annex (7): Approval from Helsinki committee- Gaza governorate 
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 ممخص الدراسة
دراسة الحالات : عوامل الاختطار لمرض ىشاشة العظام بين البالغين في محافظات غزة: "ىذه الدراسة بعنوان
عمى الصعيد العالمي يعتبر مرض ىشاشة العظام من مشاكل العظام الأكثر شيوعًا حول العالم ". والشواىد
والتي تؤثر خاصة عمى البالغين وكبار السن ويدعى ىذا المرض بالمرض الصامت حيث لا يعمم المصاب بو 
 .حتى يصاب بكسر بأحد عظامو
، حيث ) حالة سميمة08 حالة مصابة بمرض ىشاشة العظام و 08(حالة  )061(تكونت عينة الدراسة من 
استخدم الباحث دراسة مقارنة بين الحالات المرضية والحالات السميمة ، وقد ُأخذت جميع الحالات من المركز 
المختص  )AXED(الفمسطيني الألماني التشخيصي خلال فترة جمع العينة؛ وذلك بعد إجراء فحص الدكسا 
 .بكشف مرض ىشاشة العظام لكل من الحالات والشواىد
 العوامل الاجتماعية(تكونت أداة الدراسة من استبانة تم إعدادىا لقياس متغيرات الدراسة 
 ، وقد قام الباحث بإجراء ) الديموغرافية، نمط العيش، الوضع الصحي الطبي، الأدوية المستخدمة
  حالة 02اختبارات الصدق والثبات للاستبانة من خلال عينة استطلاعية تكونت من 
، وقد تم تضمينيم في عينة  الدراسة، وقد استخدم الباحث الحزمة ) شواىد01 حالات و 01(
لإجراء بعض الاختبارات الإحصائية  ))SSPS( ecneicS laicoS fo egakcaP lacitsitatS(الإحصائية
 .مثل مربع كاي والانحدار المتعدد
وقد أظير اختبار الانحدار المتعدد لإيجاد عوامل الاختطار لمرض ىشاشة العظام أن ىناك علاقة ذات دلالة 
الرضاعة الطبيعية، التاريخ العائمي للإصابة بالمرض، (إحصائية بين الإصابة بمرض ىشاشة العظام وبين 
في حين أن زيادة الوزن اعتبرت كعامل حماية من  )استخدام مدرات البول اللازكس، استخدام أدوية الضغط
 .الإصابة بمرض ىشاشة العظام
كذلك أظيرت نتائج الدراسة أن الحالات التي تستخدم الرضاعة الطبيعية تزداد معدل إصابتيم بالمرض بمعدل 
أكثر من النساء المواتي يستخدمن الرضاعة الصناعية لأطفالين كما وأظير الانحدار المتعدد  )634.1 :RO(
أن الحالات التي لدييا تاريخ عائمي للإصابة بمرض ىشاشة العظام تزداد معدل إصابتيم بالمرض بمعدل 
أكثر من الذين ليس لذوييم تاريخ عائميملإصابة بمرض ىشاشة العظام، كما وأظيرت النتائج  )548.3:RO(
أن الحالات التي تتناول أدوية مثل مدرات البول اللازكس وأدوية الضغط تزداد معدل الإصابة لدييم بمرض 
عمى التوالي أكثر من الذين لا يستخدمون مثل ىذه  )400.3 :RO ;769.6 :RO(ىشاشة العظام بمعدل
 .الأدوية
 :RO(في حيث أظيرت نتائج الدراسة أن زيادة الوزن تشكل عامل حماية من الإصابة بمرض ىشاشة العظام 
 .من الأشخاص الذين يعانون من النحافة )178.0
وتوصي ىذه الدراسة بالاىتمام بعوامل الاختطار الناتجة عن استخدام بعض الأدوية المسببة لمرض ىشاشة 
 .العظام
